{
  "meta": {
    "title": "00099_Late_Night_Pyq_Pyt_Marathon_Medicine-9",
    "url": "https://brainandscalpel.vercel.app/00099-late-night-pyq-pyt-marathon-medicine-9-016b3622.html",
    "scrapedAt": "2025-11-29T17:25:56.444Z"
  },
  "questions": [
    {
      "id": 51731,
      "choices": [
        {
          "id": 206441,
          "text": "<p><span style=\"font-size:16px;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 206442,
          "text": "<p><span style=\"font-size:16px;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 206443,
          "text": "<p><span style=\"font-size:16px;\">Sturge-Weber syndrome</span></p>"
        },
        {
          "id": 206444,
          "text": "<p><span style=\"font-size:16px;\">Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Koenen's tumors are characteristically associated with which condition? (NEET PG 2014)</span></p>",
      "unique_key": "Q7821929",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Tuberous Sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Koenen's tumors, or periungual fibromas, are benign skin growths commonly found around the nails. These tumors are a distinctive feature of tuberous sclerosis, a genetic disorder that causes non-cancerous tumors to form in many different organs, primarily the brain, eyes, heart, kidney, skin, and lungs. The presence of these tumors is one of the major clinical criteria used to diagnose tuberous sclerosis. They typically develop during puberty or later.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;A.&nbsp;Neurofibromatosis:</strong> Incorrect. While neurofibromatosis can produce skin tumors, these are usually neurofibromas, which are different from the fibromas seen in tuberous sclerosis.</span></p><p><br><span style=\"font-size:16px;\"><strong>Option&nbsp;C.&nbsp;Sturge-Weber syndrome:</strong> Incorrect. Sturge-Weber syndrome is associated with port-wine stains and neurological abnormalities, not Koenen's tumors.</span></p><p><br><span style=\"font-size:16px;\"><strong>Option&nbsp;D.&nbsp;Tuberculosis:</strong> Incorrect. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs, and does not cause Koenen's tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Koenen's tumors are associated with tuberous sclerosis and are indicative of the disease's complex multisystem involvement. The appearance of these tumors can help in the clinical diagnosis of tuberous sclerosis, particularly in patients with other neurocutaneous features.</span></p>",
      "correct_choice_id": 206442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45175,
      "choices": [
        {
          "id": 180347,
          "text": "<p><span style=\"font-size:16px;\">THIAZIDE</span></p>"
        },
        {
          "id": 180348,
          "text": "<p><span style=\"font-size:16px;\">FUROSEMIDE</span></p>"
        },
        {
          "id": 180349,
          "text": "<p><span style=\"font-size:16px;\">SPIRONOLACTONE</span></p>"
        },
        {
          "id": 180350,
          "text": "<p><span style=\"font-size:16px;\">AMILORIDE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which medication does Gitelman’s syndrome pharmacologically resemble? NEET 2016:&nbsp;</span></p>",
      "unique_key": "Q5587781",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289579,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Thiazide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Gitelman’s syndrome is closely related to the effects of thiazide diuretics due to a mutation in the Na-Cl co-transporter in the distal convoluted tubule (DCT) of the kidney. This mutation results in symptoms similar to those produced by thiazide diuretics, such as hypokalemic metabolic alkalosis and salt-wasting. The syndrome typically presents a milder clinical course compared to other conditions such as Bartter’s syndrome, with additional features like hypocalciuria and severe hypomagnesemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>B. Furosemide:</strong> Incorrect as furosemide acts on the thick ascending limb of the loop of Henle, not the DCT.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C. Spironolactone:</strong> Incorrect because it is a potassium-sparing diuretic, opposite in effect to the salt-wasting seen in Gitelman’s.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D. Amiloride:</strong> Incorrect as amiloride also conserves potassium, which does not align with the hypokalemia observed in Gitelman’s syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Gitelman’s syndrome mirrors the effects of thiazide diuretics due to its impact on the Na-Cl co-transporter in the distal convoluted tubule.</span></p>",
      "correct_choice_id": 180347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47983,
      "choices": [
        {
          "id": 191527,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 191528,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomagnesemia</span></p>"
        },
        {
          "id": 191529,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyponatremia</span></p>"
        },
        {
          "id": 191530,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common cause of Central Pontine Myelinolysis (CPM) is the rapid correction of? (NEET PG 2017)</span></p>",
      "unique_key": "Q2352345",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289580,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Hyponatremia.</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome (ODS), is most commonly caused by rapid correction of hyponatremia. Overly rapid correction of hyponatremia (&gt;8–10 mM in 24 h or 18 mM in 48 h) disrupts the integrity of the blood-brain barrier, allowing immune mediators to enter and contribute to demyelination. The lesions of ODS classically affect the pons, where the delay in reaccumulation of osmotic osmolytes is particularly pronounced.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option</strong> A. <strong>Hypokalemia</strong>: While hypokalemia can cause various neurological symptoms including weakness and paralysis, it is not the primary cause of CPM. Neurological manifestations of hypokalemia differ from the characteristic demyelinating pattern seen in CPM.</p><p>&nbsp;</p><p><strong>Option</strong> B. <strong>Hypomagnesemia</strong>: Hypomagnesemia can exacerbate hyponatremia and potentiate hypokalemia, but it is not directly implicated as a cause of CPM. Magnesium disorders have distinct neurological manifestations.</p><p>&nbsp;</p><p><strong>Option</strong> D. <strong>Hypocalcemia</strong>: Hypocalcemia causes neuromuscular irritability, tetany, and seizures, but is not associated with the development of demyelinating lesions in the pons characteristic of CPM.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Central pontine myelinolysis occurs when chronic hyponatremia is corrected too rapidly, causing asymmetric reaccumulation of brain osmolytes and subsequent demyelination, particularly affecting the pons. The safest correction rate for chronic hyponatremia is less than 8-10 mEq/L in 24 hours or 18 mEq/L in 48 hours.</p>",
      "correct_choice_id": 191529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11203,
      "choices": [
        {
          "id": 44778,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus</span></p>"
        },
        {
          "id": 44779,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 44780,
          "text": "<p><span style=\"font-size:12.0pt;\">Coagulase negative staphylococci</span></p>"
        },
        {
          "id": 44781,
          "text": "<p><span style=\"font-size:12.0pt;\">HACEK organisms</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient develops prosthetic valve endocarditis 2 years after valve replacement surgery. Which of the following organisms is the most likely cause? (NEET PG 2018)</span></p>",
      "unique_key": "Q6787494",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Streptococcus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Streptococcus, particularly Streptococcus viridans, is the most likely cause of prosthetic valve endocarditis (PVE) occurring late (more than 12 months after surgery). In the context of PVE, late cases are often similar to native valve endocarditis where Streptococcus viridans is a common pathogen due to its ability to adhere to damaged heart valves and form biofilms. The presentation of endocarditis 2 years post-surgery aligns with this etiological pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Staphylococcus aureus:&nbsp;</strong>While a common cause of early prosthetic valve endocarditis (within the first 2 months), its prevalence decreases as the time post-surgery increases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Coagulase negative staphylococci (CONS):&nbsp;</strong>These are more typical in early PVE cases, often within the first 2 months post-surgery, associated with intraoperative contamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HACEK organisms:&nbsp;</strong>These are a less common cause of endocarditis and are generally not the leading pathogens in prosthetic valve infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Prosthetic Valve Endocarditis:</strong></i></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><i><strong>Early (&lt; 2 months):&nbsp;</strong>CONS &gt; S. Aureus</i></span></li><li><span style=\"font-size:12.0pt;\"><i><strong>Late (&gt; 2-12 months): </strong>Similar to native valve -S. viridans</i></span></li></ul>",
      "correct_choice_id": 44778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66638,
      "choices": [
        {
          "id": 265693,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 265694,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral Labetalol</span></p>"
        },
        {
          "id": 265695,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Labetalol</span></p>"
        },
        {
          "id": 265696,
          "text": "<p><span style=\"font-size:12.0pt;\">Ramipril</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant female who is a known case of diabetes mellitus presented with severe hypertension (BP 180/110 mmHg) with proteinuria and headache at 32 weeks of gestation. Which of the following is the preferred drug for this patient? (Twisted PYQ)&nbsp;</span></p>",
      "unique_key": "Q7864932",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IV Labetalol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In severe preeclampsia (as evidenced by severe hypertension, proteinuria, and symptoms), IV labetalol is the first-line treatment. It provides rapid and controlled blood pressure reduction with fewer side effects. IV labetalol is particularly suitable for this case as it doesn't adversely affect glucose metabolism in diabetic patients and has a proven safety profile in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nifedipine:</strong> While safe in pregnancy, oral medications are not preferred in severe preeclampsia where rapid BP control is needed. Additionally, calcium channel blockers may interfere with glucose control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oral Labetalol:</strong> In severe hypertension during pregnancy, oral medications are not the first choice when immediate BP control is needed. IV route provides more predictable and rapid response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ramipril:</strong> ACE inhibitors are absolutely contraindicated throughout pregnancy due to risk of fetal renal damage, oligohydramnios, and other congenital abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IV labetalol is the first-line treatment for severe preeclampsia, offering rapid and controlled BP reduction. It's particularly suitable for diabetic patients as it doesn't significantly affect glucose metabolism.</span></p>",
      "correct_choice_id": 265695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47515,
      "choices": [
        {
          "id": 189671,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis 1</span></p>"
        },
        {
          "id": 189672,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis 2</span></p>"
        },
        {
          "id": 189673,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis 4</span></p>"
        },
        {
          "id": 189674,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureterosigmoidostomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia is seen in all of the following conditions, except? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q2347915",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289583,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Renal tubular acidosis 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Renal tubular acidosis type 4 (hyperkalemic RTA)&nbsp;</strong>is distinct from the other types as it is characterized by hyperkalemia (high potassium levels). It is typically caused by aldosterone deficiency or resistance, leading to impaired potassium secretion. This condition is often associated with Addison's disease, or can be induced by medications such as <strong>ACE inhibitors, ARBs, calcineurin inhibitors, heparin, NSAIDs, and potassium-sparing diuretics.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypokalemia, or low potassium levels, is commonly seen in several conditions that lead to normal anion gap metabolic acidosis (NAGMA). These include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Renal tubular acidosis (RTA) type 1 (Distal RTA):&nbsp;</strong>This condition is characterized by a defect in hydrogen ion secretion in the distal nephron, leading to hypokalemia, hypercalciuria, nephrocalcinosis, and recurrent kidney stones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Renal tubular acidosis type 2 (Proximal RTA):&nbsp;</strong>This condition involves a defect in bicarbonate reabsorption in the proximal tubule, leading to hypokalemia, bicarbonate wasting, and associated Fanconi syndrome (a combination of aminoaciduria, glycosuria, phosphaturia, and bone disorders such as rickets and osteomalacia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ureterosigmoidostomy:&nbsp;</strong>This surgical procedure can lead to hypokalemia due to the reabsorption of urinary ammonium and chloride, resulting in a metabolic acidosis with hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Renal tubular acidosis type 4 is the exception among conditions causing hypokalemia, as it leads to hyperkalemia due to aldosterone deficiency or resistance.</span></p>",
      "correct_choice_id": 189673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24773,
      "choices": [
        {
          "id": 99053,
          "text": "<p><span style=\"font-size:11.0pt;\">B12 deficiency</span></p>"
        },
        {
          "id": 99054,
          "text": "<p><span style=\"font-size:11.0pt;\">Normal pressure hydrocephalus</span></p>"
        },
        {
          "id": 99055,
          "text": "<p><span style=\"font-size:11.0pt;\">Lewy body dementia</span></p>"
        },
        {
          "id": 99056,
          "text": "<p><span style=\"font-size:11.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is not a cause of reversible dementia? (INICET MAY 2023)</span></p>",
      "unique_key": "Q8060426",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289584,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;Lewy body dementia</strong></span></p><p><br><span style=\"font-size:12pt;\">Lewy body dementia is a progressive and irreversible neurodegenerative disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. B12 deficiency:</strong> Reversible with supplementation.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Normal pressure hydrocephalus:</strong> Reversible with shunting.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hypothyroidism:</strong> Reversible with thyroid hormone replacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lewy body dementia is not a reversible cause of dementia.</span></p>",
      "correct_choice_id": 99055,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11647,
      "choices": [
        {
          "id": 46554,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">To be done in lateral recumbent position</span></p>"
        },
        {
          "id": 46555,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Breath holding is not necessary</span></p>"
        },
        {
          "id": 46556,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The bevel should face upwards while inserting the needle.</span></p>"
        },
        {
          "id": 46557,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Coagulopathy is not a contraindication.</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Regarding the procedure done with the needle shown below, which of the following is false?</span><span style=\"font-size:12.0pt;\"> (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm108.jpg\" alt=\"\" width=\"400\" height=\"302\"></span></p>",
      "unique_key": "Q5641428",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289585,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Coagulopathy is not a contraindication.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts a spinal needle used primarily for lumbar puncture (LP), a procedure where cerebrospinal fluid (CSF) is collected from the lumbar cistern. The procedure can be conducted in either the lateral recumbent position or sitting position, depending on the patient's comfort and the physician's preference. The bevel orientation during insertion affects the dural fibers; positioning it parallel (typically upwards) minimizes dural fiber tearing and the subsequent likelihood of post-lumbar puncture headaches. Importantly, coagulopathy is a significant contraindication for lumbar puncture due to the increased risk of spinal hematoma and severe complications associated with bleeding around the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To be done in lateral recumbent position:</strong> This is true and is one of the standard positions for performing an LP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Breath holding is not necessary:</strong> During LP, patients are advised to breathe normally to avoid increases in intra-abdominal and intrathoracic pressure, which could affect CSF dynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The bevel should face upwards while inserting the needle:</strong> This is a recommended practice to reduce the risk of post-procedure complications, such as a post-dural puncture headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coagulopathy is a contraindication for lumbar puncture due to the risk of bleeding and potential for serious complications, contrary to the incorrect statement provided. Always assess the patient’s coagulation status prior to performing an LP.</span></p>",
      "correct_choice_id": 46557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11760,
      "choices": [
        {
          "id": 47006,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
        },
        {
          "id": 47007,
          "text": "<p><span style=\"font-size:12.0pt;\">Budd Chiari syndrome</span></p>"
        },
        {
          "id": 47008,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 47009,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">50 yr old gentleman presented with progressive abdominal distension with shifting dullness on examination and dilated veins on lateral chest wall. Ascitic fluid analysis given below. What is the likely diagnosis? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105207.png\" alt=\"\" width=\"1000\" height=\"462\"></span></p>",
      "unique_key": "Q2895738",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289586,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Budd-Chiari syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presence of lateral dilated veins with high SAAG, low protein suggests Late Budd-Chiari syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SAAG=Serum albumin- Ascitic Albumin = 2g/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Interpretation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">≥1.1: Portal Hypertension (Transudate)</span></li><li><span style=\"font-size:12.0pt;\">&lt;1.1: Exudate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ascitic fluid protein helps identify sinusoidal vs non-sinusoidal causes</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Ascitic fluid protein &gt;2.5 = non-sinusoidal&nbsp;&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Congestive Heart Failure</strong>: Typically presents with high SAAG and high protein content in the ascitic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cirrhosis</strong>: While cirrhosis can also present with high SAAG, it usually shows low protein content in the ascitic fluid, which aligns with this case, but the presence of dilated veins specific to Budd-Chiari provides a more accurate diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberculosis</strong>: Tuberculous peritonitis typically presents with a low SAAG and high protein content, which is inconsistent with the findings in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105251.png\" alt=\"\" width=\"1000\" height=\"350\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hepatology/ascites</strong></span></p>",
      "correct_choice_id": 47007,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11247,
      "choices": [
        {
          "id": 44954,
          "text": "<p><span style=\"font-size:12.0pt;\">Left atrium</span></p>"
        },
        {
          "id": 44955,
          "text": "<p><span style=\"font-size:12.0pt;\">Right atrium</span></p>"
        },
        {
          "id": 44956,
          "text": "<p><span style=\"font-size:12.0pt;\">Left ventricle</span></p>"
        },
        {
          "id": 44957,
          "text": "<p><span style=\"font-size:12.0pt;\">Right ventricle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which cardiac chamber enlargement is seen in the case of mitral stenosis on chest X-ray initially? (NEET PG 2019)</span></p>",
      "unique_key": "Q6279232",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289587,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Left atrium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of mitral stenosis (MS), the obstruction at the mitral valve leads to increased pressure in the left atrium as it works harder to pump blood through the narrowed valve. This increased pressure causes the left atrium to dilate. This dilation can be identified on a chest X-ray as enlargement of the left atrial silhouette. The left atrium enlargement is often the earliest and most prominent cardiac chamber change seen in mitral stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right atrium:&nbsp;</strong>Right atrium enlargement generally occurs later in the course of mitral stenosis as a consequence of the elevated pressure being transmitted back through the lungs to the right side of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Left ventricle:&nbsp;</strong>The left ventricle is typically not directly affected by mitral stenosis, as this condition primarily impacts the left atrium. Left ventricular enlargement would be more characteristic of conditions affecting the left ventricular outflow or volume overload.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Right ventricle:&nbsp;</strong>Right ventricular enlargement may eventually occur if the disease progresses to the point of causing pulmonary hypertension, which then puts a strain on the right ventricle. However, this is a later development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitral stenosis primarily leads to enlargement of the left atrium as the initial response to increased pressure upstream of the stenotic mitral valve. Recognition of this early sign on a chest X-ray can be crucial for diagnosing and managing mitral stenosis effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/VHD</strong></span></p>",
      "correct_choice_id": 44954,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11599,
      "choices": [
        {
          "id": 46362,
          "text": "<p><span style=\"font-size:12.0pt;\">Rewarming is the treatment of choice</span></p>"
        },
        {
          "id": 46363,
          "text": "<p><span style=\"font-size:12.0pt;\">Analgesics are contraindicated</span></p>"
        },
        {
          "id": 46364,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombolytics can be used</span></p>"
        },
        {
          "id": 46365,
          "text": "<p><span style=\"font-size:12.0pt;\">Amputation in severe cases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A soldier operating in Siachen Glacier presents with numbness of his legs. Incorrect regarding the image given:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154108.png\" alt=\"\" width=\"300\" height=\"170\"></p>",
      "unique_key": "Q9708330",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289588,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Analgesics are contraindicated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient described is likely suffering from frostbite, given the environmental conditions and symptoms of numbness and the visual sign of erythema on the toes. Frostbite occurs when skin and other tissues freeze due to exposure to extremely cold temperatures. The treatment and management of <strong>frostbite</strong> are critical to prevent long-term damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Analgesics are contraindicated:</strong> This is incorrect. Analgesics, especially opiate analgesics, are crucial during the rewarming process because it is extremely painful. Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided due to their potential to cause further vasoconstriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rewarming is the treatment of choice:</strong> This is correct. The first line of treatment for frostbite is rapid rewarming in a water bath at 37-39°C (98.6-102.2°F). This helps to restore blood flow and minimize tissue damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thrombolytics can be used:&nbsp;</strong>This is correct. In cases where frostbite is severe and the patient presents within 24 hours, thrombolytic therapy may be considered to restore blood flow and prevent tissue death. <strong>MR angiography</strong> can help assess the need for thrombolytics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amputation in severe cases:&nbsp;</strong>This is correct. In severe frostbite cases, where there is significant tissue necrosis, amputation may be necessary. This is typically decided based on a <strong>bone scan</strong> if the patient presents more than 24 hours after the injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For frostbite treatment, rewarming is essential, analgesics are indicated due to the pain associated with rewarming, thrombolytics can be used within 24 hours of injury, and amputation may be necessary in severe cases.</span></p>",
      "correct_choice_id": 46363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16166,
      "choices": [
        {
          "id": 64624,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart failure</span></p>"
        },
        {
          "id": 64625,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver failure</span></p>"
        },
        {
          "id": 64626,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 64627,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of exudative pleural effusion? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q7629486",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289589,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Rheumatoid arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why Rheumatoid Arthritis is Correct:</strong> Rheumatoid arthritis is an inflammatory condition that can lead to the accumulation of exudative pleural effusion. Exudative effusions are characterized by high protein content and cellular debris resulting from increased capillary permeability typically due to inflammation or injury to the pleural membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of an exudative pleural effusion is confirmed using <strong>Light's criteria</strong>, which states that a pleural effusion is exudative if at least one of the following is true:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Pleural fluid protein/serum protein ratio &gt; 0.5</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH/serum LDH ratio &gt; 0.6</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH more than two-thirds the upper limit of normal serum LDH</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Heart failure:</strong> Heart failure typically causes a transudative pleural effusion, which results from increased hydrostatic pressure or decreased oncotic pressure without inflammation. The pleural fluid in transudative effusions has low protein content and is generally less cellular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Heart failure is currently the most common cause of pleural effusion (MC cause of transudative pleural effusion).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liver failure:&nbsp;</strong>Liver failure leads to a <strong>transudative pleural effusion</strong> due to the accumulation of fluid in the abdomen (ascites) that moves into the pleural space, also known as hepatic hydrothorax. This is due to the RAS-activated state causing low protein content in the effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nephrotic syndrome:&nbsp;</strong>Nephrotic syndrome causes a <strong>transudative pleural effusion</strong>. The loss of protein in the urine leads to low serum albumin levels and decreased oncotic pressure, resulting in fluid accumulation in the pleural space.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exudative pleural effusions are typically caused by conditions that involve inflammation or injury to the pleura, such as rheumatoid arthritis, while transudative effusions are usually due to systemic conditions like heart failure, liver failure, and nephrotic syndrome that affect hydrostatic or oncotic pressure.</span></p>",
      "correct_choice_id": 64626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11477,
      "choices": [
        {
          "id": 45874,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 45875,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 45876,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia</span></p>"
        },
        {
          "id": 45877,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old male admitted to the ICU for acute exacerbation of COPD develops a sudden onset of palpitations. The following ECG changes are seen. What is the most likely diagnosis? (AIIMS MAY 2019)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm69.jpg\" alt=\"\" width=\"300\" height=\"138\"></span></p>",
      "unique_key": "Q7409445",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289590,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Multifocal atrial tachycardia&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture44.jpg\" alt=\"\" width=\"1000\" height=\"741\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>VT is usually regular and wide QRS tachycardia (QRS &gt; 120ms).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>P waves usually absent in AF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Atrial tachycardia is regular narrow QRS tachycardia with fixed morphology of P wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MAT is usually associated with lung disease and occurs secondary to underlying hypoxemia.</span></li><li><span style=\"font-size:12.0pt;\">Treatment is with <strong>CCB &gt; BB&nbsp;</strong>to slow the atrial, ventricular rate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardioversion is ineffective and contraindicated in this rhythm.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multifocal Atrial Tachycardia is characterized by multiple ectopic atrial activities leading to variable P wave morphologies and an irregular rhythm, often associated with underlying chronic pulmonary conditions. Management focuses on treating the underlying condition and stabilizing the rate with appropriate medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/chap 250/7033</strong></span></p>",
      "correct_choice_id": 45876,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54259,
      "choices": [
        {
          "id": 216505,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compressions at 100-120/min</span></p>"
        },
        {
          "id": 216506,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow adequate chest recoil</span></p>"
        },
        {
          "id": 216507,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compression to Rescue breath ratio is 30:2</span></p>"
        },
        {
          "id": 216508,
          "text": "<p><span style=\"font-size:12.0pt;\">Depth of compression must be 3-4cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Which of the following is incorrect regarding High-Quality CPR?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8354104",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289591,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Depth of compression must be 3-4cm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement \"Depth of compression must be 3-4cm\" is incorrect for high-quality CPR. The correct depth of chest compression for adults is approximately <strong>5 centimeters (or 2 inches). </strong>This depth ensures adequate blood flow during cardiopulmonary resuscitation. The 3-4cm depth mentioned in the option is insufficient for effective CPR in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chest compressions at 100-120/min:</strong> This is correct. The recommended rate for chest compressions during CPR is 100-120 compressions per minute. This rate optimizes blood flow during resuscitation efforts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Allow adequate chest recoil:</strong> This statement is correct. Allowing full chest recoil between compressions is crucial for effective CPR. It enables proper diastolic filling of the heart, improving overall circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chest compression to Rescue breath ratio is 30:2:</strong> This is also correct. For adult CPR without an advanced airway, the standard ratio is 30 chest compressions followed by 2 rescue breaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-quality CPR for adults, the correct depth of chest compressions is approximately 5 centimeters (2 inches), not 3-4cm as stated in the incorrect option.</span></p>",
      "correct_choice_id": 216508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66640,
      "choices": [
        {
          "id": 265701,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5-1°C per hour</span></p>"
        },
        {
          "id": 265702,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5-1°C per 2 hours</span></p>"
        },
        {
          "id": 265703,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5-2°C per hour</span></p>"
        },
        {
          "id": 265704,
          "text": "<p><span style=\"font-size:12.0pt;\">2-4°C per hour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In primary accidental hypothermia, what is the usual rate of core body temperature increase during active external rewarming with forced-air warming blankets? (Twisted PYQ)&nbsp;</span></p>",
      "unique_key": "Q3147938",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289592,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 0.5-2°C per hour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Explanation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary accidental hypothermia refers to an unintentional drop in core body temperature due to environmental exposure. The management of hypothermia includes rewarming strategies, which can be classified into passive and active rewarming.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Passive External Rewarming: This method involves insulating the patient by covering them with blankets and ensuring that the head is also covered. It relies on the patient's own heat production to gradually increase body temperature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to standard medical guidelines and Harrison's principles, passive external rewarming can increase the core body temperature by approximately 0.5 to 2°C per hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of primary accidental hypothermia, passive external rewarming can raise the core body temperature by 0.5 to 2°C per hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information </strong>–</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothermia based on core body temperature and corresponding treatment methods:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mild Hypothermia:</strong></span></p><p><span style=\"font-size:12.0pt;\">Core Body Temperature: Less than 35 degrees Celsius.</span></p><p><span style=\"font-size:12.0pt;\">Treatment: Passive external rewarming is the treatment of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Moderate Hypothermia:</strong></span></p><p><span style=\"font-size:12.0pt;\">Core Body Temperature: Less than 32 degrees Celsius.</span></p><p><span style=\"font-size:12.0pt;\">Treatment: Requires both passive and active rewarming methods. Passive rewarming involves external methods, while active rewarming can be either external or internal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Severe Hypothermia</strong></span></p><p><span style=\"font-size:12.0pt;\">Core Body Temperature: Less than 28 degrees Celsius.</span></p><p><span style=\"font-size:12.0pt;\">Treatment: Requires both passive and active rewarming methods. Passive rewarming involves external methods, while active rewarming can be either external or internal.</span></p>",
      "correct_choice_id": 265703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11276,
      "choices": [
        {
          "id": 45070,
          "text": "<p><span style=\"font-size:12.0pt;\">Necrotizing inflammation of large vessels</span></p>"
        },
        {
          "id": 45071,
          "text": "<p><span style=\"font-size:12.0pt;\">Patient has hypogammaglobulinemia</span></p>"
        },
        {
          "id": 45072,
          "text": "<p><span style=\"font-size:12.0pt;\">90% is associated with ANCA positivity</span></p>"
        },
        {
          "id": 45073,
          "text": "<p><span style=\"font-size:12.0pt;\">30% is associated with Hepatitis B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about polyarteritis nodosa? (NEET PG 2020)</span></p>",
      "unique_key": "Q8887469",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289593,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 30% association with Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly affecting medium-sized arteries, often associated with Hepatitis B in about 30% of cases. The association with Hepatitis B is significant because the virus can trigger immune complex deposition, contributing to vascular inflammation and damage characteristic of PAN.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Necrotizing inflammation of large vessels:&nbsp;</strong>This is incorrect because PAN specifically affects medium-sized, not large vessels. Large vessel vasculitis includes conditions like Giant Cell Arteritis and Takayasu Arteritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Patient has hypogammaglobulinemia:&nbsp;</strong>This is incorrect; PAN is often associated with hypergammaglobulinemia due to chronic immune activation, not hypogammaglobulinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 90% is associated with ANCA positivity:&nbsp;</strong>This statement is also incorrect. Polyarteritis nodosa is typically ANCA-negative; the presence of ANCA is more characteristic of other forms of vasculitis such as Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-104010.jpg\" alt=\"\" width=\"1000\" height=\"772\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p>",
      "correct_choice_id": 45073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47634,
      "choices": [
        {
          "id": 190147,
          "text": "<p><span style=\"font-size:12.0pt;\">75%</span></p>"
        },
        {
          "id": 190148,
          "text": "<p><span style=\"font-size:12.0pt;\">45%</span></p>"
        },
        {
          "id": 190149,
          "text": "<p><span style=\"font-size:12.0pt;\">Always Present</span></p>"
        },
        {
          "id": 190150,
          "text": "<p><span style=\"font-size:12.0pt;\">No epilepsy risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">After a severe penetrating head trauma, what is the risk of subsequent epilepsy? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q5328344",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289594,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 45%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to Harrison's Principles of Internal Medicine, the risk of developing subsequent epilepsy after severe penetrating head trauma is approximately 45%. This statistic highlights the significant risk associated with severe brain injuries, particularly those involving penetration, which can lead to long-term neurological complications such as epilepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of developing epilepsy after severe penetrating head trauma is approximately 45%.</span></p>",
      "correct_choice_id": 190148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11447,
      "choices": [
        {
          "id": 45754,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HCV, Anti HEV</span></p>"
        },
        {
          "id": 45755,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</span></p>"
        },
        {
          "id": 45756,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HDV, Anti-HEV, Anti-HCV</span></p>"
        },
        {
          "id": 45757,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, IgM anti-HBc, Anti-HCV, Anti-HEV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 40-year-old male chronic smoker presents to the AIIMS OPD with fever, fatigue, yellow-colored urine, and RUQ pain. For the past few days, he has developed an aversion to eating food. On examination icterus was present. What investigations would you advise to rule out acute viral hepatitis? (AIIMS MAY 2018)</span></p><p><br><span style=\"font-size:16px;\">Liver function test results are given below:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Total Bilirubin 18.5</span></li><li><span style=\"font-size:16px;\">Direct Bilirubin 10.5&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:16px;\">SGOT/AST 723</span></li><li><span style=\"font-size:16px;\">SGPT/ALT 812</span></li></ul>",
      "unique_key": "Q8239575",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289595,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Above history is suggestive of acute viral hepatitis with ALT&gt;AST and elevated &gt;10X times. With resolution of symptoms jaundice gradually increases and spontaneously improves.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Common causes of AST, ALT &gt; 10X are Viral Hepatitis (B, A, C-rare, E-In pregnancy/Post-transplant), Toxins, Shock liver, Fulminant Wilsons.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. </strong>Anti-HEV testing routinely not employed</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.&nbsp;</strong>Hepatitis D usually causes severe disease when B+D coinfection occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.&nbsp;</strong>HbsAg is first test of hep B infection W/IgM HbC suggest FLARE, window period, acute infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases of suspected acute viral hepatitis with significant liver enzyme elevation and icterus, it's essential to conduct a thorough serological evaluation to determine the specific type of hepatitis virus involved. This allows for targeted management and appropriate precautions to prevent transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reference: Harrison/gastroenterology/Viral Hepatitis/Chap 339</strong></span></p>",
      "correct_choice_id": 45755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11801,
      "choices": [
        {
          "id": 47170,
          "text": "<p><span style=\"font-size:12.0pt;\">Regardless of ejection fraction and the type of heart failure, the 5-year mortality rate is around 50%.</span></p>"
        },
        {
          "id": 47171,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-cardiovascular death is more in HFrEF as compared to HFpEF.</span></p>"
        },
        {
          "id": 47172,
          "text": "<p><span style=\"font-size:12.0pt;\">ACEi cause cough in 15% and angioedema in 1%.</span></p>"
        },
        {
          "id": 47173,
          "text": "<p><span style=\"font-size:12.0pt;\">AF is common in the elderly and is the cause of stroke in a quarter of stroke cases.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding heart failure except: (INICET NOV 2021)</span></p>",
      "unique_key": "Q6756854",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289596,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Non-cardiovascular death is more in HFrEF as compared to HFpEF.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-cardiovascular death refers to mortality due to causes other than cardiovascular diseases, such as infections, accidents, or malignancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The majority of deaths in HFrEF (Heart Failure with reduced Ejection Fraction) are due to cardiovascular causes (85%), and only 15% are due to non-cardiovascular causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, in HFpEF (Heart Failure with preserved Ejection Fraction), 60% of deaths are cardiovascular, and 40% are non-cardiovascular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, non-cardiovascular death is actually more prevalent in HFpEF patients compared to HFrEF patients, making option B incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Regardless of ejection fraction and the type of heart failure, the 5-year mortality rate is around 50%: </strong>This statement is correct. Both HFpEF and HFrEF patients have similar 5-year mortality rates, approximately 50%. This indicates that having a preserved ejection fraction does not necessarily correlate with a better long-term survival rate compared to reduced ejection fraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ACEi cause cough in 15% and angioedema in 1%: </strong>This statement is correct. Angiotensin-Converting Enzyme inhibitors (ACEi) are known to cause a persistent cough in about 15% of patients and angioedema, a more serious but less common side effect, in approximately 1% of patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>AF is common in the elderly and is the cause of stroke in a quarter of stroke cases: </strong>This statement is correct. Atrial Fibrillation (AF) is indeed common among elderly patients and is a significant cause of cardioembolic strokes, accounting for about 25% of such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-cardiovascular deaths are more common in HFpEF patients compared to HFrEF patients.</span></p>",
      "correct_choice_id": 47171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20261,
      "choices": [
        {
          "id": 81005,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 81006,
          "text": "<p><span style=\"font-size:12.0pt;\">Squatting</span></p>"
        },
        {
          "id": 81007,
          "text": "<p><span style=\"font-size:12.0pt;\">Valsalva</span></p>"
        },
        {
          "id": 81008,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy? (NEET PG 2023)</span></p>",
      "unique_key": "Q9642752",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Squatting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hypertrophic cardiomyopathy (HCM), the intensity of the murmur is influenced by the left ventricular outflow tract (LVOT) obstruction. Various maneuvers and medications can affect this obstruction by altering preload (the volume of blood in the ventricles before contraction) or afterload (the resistance the heart must pump against).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Squatting</strong> increases preload by squeezing the peripheral veins and increasing venous return to the heart. This increase in preload reduces LVOT obstruction, thereby decreasing the murmur's intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Digoxin:</strong> Digoxin increases contractility. In HCM, increased contractility can worsen LVOT obstruction, thereby increasing the intensity of the murmur and worsening the murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Valsalva</strong>: The Valsalva maneuver reduces preload by decreasing venous return to the heart. This reduction in preload can increase LVOT obstruction, leading to a louder murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Furosemide</strong>: By reducing preload, furosemide increases LVOT obstruction and murmur intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Increasing preload (e.g., through squatting) reduces LVOT obstruction in hypertrophic cardiomyopathy, leading to a decrease in the murmur's intensity.</span></p>",
      "correct_choice_id": 81006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11709,
      "choices": [
        {
          "id": 46802,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
        },
        {
          "id": 46803,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 46804,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol</span></p>"
        },
        {
          "id": 46805,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The drug of choice for treating scrub typhus? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q6418774",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289598,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus, caused by <i>Orientia tsutsugamushi</i>, is effectively treated with Doxycycline, which is considered the first-line treatment. Doxycycline is administered at a dosage of 100 mg twice daily for 7 to 14 days. It disrupts protein synthesis in the bacterium, which is crucial for its effectiveness against this intracellular pathogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy/children- Azithromycin/ chloramphenicol preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ciprofloxacin:&nbsp;</strong>While it is a broad-spectrum antibiotic, it is not the preferred treatment for scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chloramphenicol:&nbsp;</strong>This is an alternative treatment option but is generally reserved for cases where doxycycline or azithromycin cannot be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Azithromycin:&nbsp;</strong>This is a suitable alternative, especially in special populations such as pregnant women and children, where doxycycline is contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Doxycycline is the first-choice medication for treating scrub typhus in adults and non-pregnant women, offering effective relief and eradication of the pathogen when taken for the recommended duration.</span></p>",
      "correct_choice_id": 46802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55391,
      "choices": [
        {
          "id": 221025,
          "text": "<p><span style=\"font-size:12pt;\">Increase resistance of afferent arteriole</span></p>"
        },
        {
          "id": 221026,
          "text": "<p><span style=\"font-size:12pt;\">Decrease resistance of efferent arteriole</span></p>"
        },
        {
          "id": 221027,
          "text": "<p><span style=\"font-size:12pt;\">Increase Bowman capsule hydrostatic pressure</span></p>"
        },
        {
          "id": 221028,
          "text": "<p><span style=\"font-size:12pt;\">Increase renal perfusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is true regarding increase in GFR? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q9509007",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289599,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Increase renal perfusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Glomerular filtration rate (GFR) is influenced by various factors, including the blood flow through the kidneys and the pressures within the glomerular capillaries. An increase in renal perfusion means an increase in blood flow to the kidneys, which enhances the filtration process and thereby increases the GFR. This can be achieved by dilation of the afferent arteriole (which increases blood flow into the glomerulus) or by constriction of the efferent arteriole (which increases the pressure within the glomerulus).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increase resistance of afferent arteriole:</strong> Increasing the resistance of the afferent arteriole means constricting it, which would reduce blood flow into the glomerulus and subsequently decrease the GFR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Decrease resistance of efferent arteriole:</strong> Decreasing the resistance of the efferent arteriole means dilating it, allowing blood to flow out of the glomerulus more easily. This reduces the pressure within the glomerulus, leading to a decrease in GFR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Increase Bowman capsule hydrostatic pressure:</strong> Increasing the hydrostatic pressure within the Bowman's capsule would oppose the filtration pressure, leading to a decrease in GFR rather than an increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Increasing renal perfusion is the most effective way to increase the glomerular filtration rate (GFR).</span></p>",
      "correct_choice_id": 221028,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11362,
      "choices": [
        {
          "id": 45414,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive jaundice</span></p>"
        },
        {
          "id": 45415,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic jaundice</span></p>"
        },
        {
          "id": 45416,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic jaundice</span></p>"
        },
        {
          "id": 45417,
          "text": "<p><span style=\"font-size:12.0pt;\">Prehepatic jaundice</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis? (Neet pg 2022)</span></p>",
      "unique_key": "Q4452205",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289600,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Obstructive jaundice</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The laboratory findings indicate elevated bilirubin and alkaline phosphatase levels while other liver enzymes are normal. This pattern is most consistent with <strong>obstructive jaundice.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this condition, there is an obstruction in the bile ducts that prevents bile from being excreted into the intestine, leading to an accumulation of conjugated bilirubin in the blood. Alkaline phosphatase is typically elevated in conditions that involve cholestasis (impaired bile flow), which is characteristic of obstructive jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemolytic jaundice</strong>: This type of jaundice is caused by the excessive breakdown of red blood cells, leading to elevated levels of unconjugated bilirubin. Alkaline phosphatase levels remain normal in hemolytic jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepatic jaundice</strong>: Hepatic jaundice occurs due to liver cell damage, which impairs the liver's ability to process and excrete bilirubin. This condition typically shows elevated transaminases (ALT, AST), not just alkaline phosphatase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prehepatic jaundice</strong>: This term is often used interchangeably with hemolytic jaundice, where the problem lies before the bilirubin reaches the liver. Elevated unconjugated bilirubin and normal alkaline phosphatase levels are seen in prehepatic jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases where laboratory investigations reveal elevated bilirubin and alkaline phosphatase with normal other liver enzymes, obstructive jaundice should be considered as the most likely diagnosis.</span></p>",
      "correct_choice_id": 45414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11728,
      "choices": [
        {
          "id": 46878,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune adrenalitis</span></p>"
        },
        {
          "id": 46879,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernephroma</span></p>"
        },
        {
          "id": 46880,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 46881,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease is commonly associated with:&nbsp;(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1342696",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289601,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Autoimmune adrenalitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Addison's disease, primarily characterized by adrenal insufficiency, is most commonly associated with autoimmune adrenalitis. In this condition, the body's immune system attacks the adrenal cortex, leading to a decrease in the production of steroid hormones such as cortisol and aldosterone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypernephroma:&nbsp;</strong>Also known as renal cell carcinoma, hypernephroma is a type of kidney cancer and has no direct link to the adrenal function or Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adrenocortical carcinoma:&nbsp;</strong>This is a cancer of the adrenal cortex but typically leads to excessive hormone production, associated more with Cushing's syndrome rather than Addison's disease, where there is hormone deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Medullary carcinoma of the thyroid:&nbsp;</strong>This type of cancer is associated with the thyroid gland and is related to multiple endocrine neoplasia type 2 (MEN2) syndrome but not directly linked to Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\">Addison's disease is most commonly caused by autoimmune adrenalitis, where the immune system mistakenly attacks the adrenal glands, leading to insufficient production of vital hormones.</span></p>",
      "correct_choice_id": 46878,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50957,
      "choices": [
        {
          "id": 203369,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 203370,
          "text": "<p><span style=\"font-size:12.0pt;\">Third degree heart block</span></p>"
        },
        {
          "id": 203371,
          "text": "<p><span style=\"font-size:12.0pt;\">Wenckebach heart block</span></p>"
        },
        {
          "id": 203372,
          "text": "<p><span style=\"font-size:12.0pt;\">Mobitz type 2 block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the diagnosis in the ECG shown below?(</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112639.png\" alt=\"\" width=\"300\" height=\"90\"></span></p>",
      "unique_key": "Q9534440",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289602,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mobitz type 2 block</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The ECG shows bradycardia with regular, constant PR intervals in the conducted beats and intermittently dropped QRS complexes, which are indicative of Mobitz type 2 block. This type of atrioventricular block is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Constant PR interval in the conducted beats</span></li><li><span style=\"font-size:12.0pt;\">Intermittent non-conducted P waves (dropped QRS complexes)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This distinguishes Mobitz type 2 block from other types of heart block:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. First degree heart block:&nbsp;</strong>Characterized by a prolonged PR interval (&gt;200 ms) but all P waves are followed by QRS complexes. This is not observed in the given ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Third degree heart block</strong>: Complete dissociation between P waves and QRS complexes, with no relationship between them. The given ECG does not show this pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Wenckebach heart block (Mobitz type 1):&nbsp;</strong>Progressive prolongation of the PR interval until a QRS complex is dropped. The given ECG shows constant PR intervals, not progressively increasing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mobitz type 2 block is identified by a constant PR interval with intermittently non-conducted P waves. Recognizing this pattern is crucial for appropriate management, as Mobitz type 2 can progress to complete heart block and often requires a pacemaker.</span></p>",
      "correct_choice_id": 203372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11508,
      "choices": [
        {
          "id": 45998,
          "text": "<p><span style=\"font-size:12.0pt;\">Responds well to amoxiclav</span></p>"
        },
        {
          "id": 45999,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest X-ray shows bilateral infiltrates</span></p>"
        },
        {
          "id": 46000,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibody are useful in diagnosis</span></p>"
        },
        {
          "id": 46001,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be cultured in a cell-free medium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false about mycoplasma pneumonia? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q7590081",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289603,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Responds well to amoxiclav</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta-lactam groups of drugs act by inhibiting the transpeptidation process of cell wall synthesis. Mycoplasma does not possess a cell wall and hence is not affected by beta-lactams.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Azithromycin (DOC)</strong>, Doxycycline, Fluoroquinolone (FQ) are effective in management of mycoplasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Interstitial inflammation characterized by bilateral reticular infiltrates are seen on CXR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>IgM, IgG can be used in the diagnosis of Mycoplasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>They show fried-egg appearance on cell free medium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mycoplasma pneumonia does not respond to beta-lactam antibiotics due to its lack of a cell wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred antibiotics for treating Mycoplasma pneumonia include macrolides (e.g., azithromycin), tetracyclines (e.g., doxycycline), and fluoroquinolones for adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Resp Med/pneumonia, Harrison chap 188/5430</strong></span></p>",
      "correct_choice_id": 45998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66642,
      "choices": [
        {
          "id": 265709,
          "text": "<p><span style=\"font-size:12.0pt;\">Lemon juice</span></p>"
        },
        {
          "id": 265710,
          "text": "<p><span style=\"font-size:12.0pt;\">Amla juice</span></p>"
        },
        {
          "id": 265711,
          "text": "<p><span style=\"font-size:12.0pt;\">Tea</span></p>"
        },
        {
          "id": 265712,
          "text": "<p><span style=\"font-size:12.0pt;\">Phytates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following substances, when consumed with oral iron, significantly enhances its absorption? (Twisted PYQ)&nbsp;</span></p>",
      "unique_key": "Q1144333",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289604,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lemon juice</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lemon juice contains high amounts of vitamin C (ascorbic acid), which significantly enhances iron absorption from the gastrointestinal tract. Vitamin C acts by converting ferric iron (Fe3+) to the more readily absorbable ferrous form (Fe2+) and helps form a soluble complex that stays stable in the alkaline environment of the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amla juice:</strong> While it also contains vitamin C, it contains other compounds that may interfere with iron absorption, making it less effective than pure citrus sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tea:</strong> Contains tannins which bind to iron and significantly reduce its absorption, making it counterproductive when taken with iron supplements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phytates:</strong> Found in whole grains and legumes, these compounds bind to iron and form insoluble complexes, reducing iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin C-rich foods like lemon juice enhance iron absorption by:</span></p><ol><li><span style=\"font-size:12.0pt;\">Converting ferric iron to ferrous iron</span></li><li><span style=\"font-size:12.0pt;\">Forming soluble complexes</span></li><li><span style=\"font-size:12.0pt;\">Maintaining iron stability in alkaline environments</span></li><li><span style=\"font-size:12.0pt;\">Counteracting the effects of absorption inhibitors</span></li></ol>",
      "correct_choice_id": 265709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11566,
      "choices": [
        {
          "id": 46230,
          "text": "<p><span style=\"font-size:12.0pt;\">CT angiography to look for large vessel occlusion</span></p>"
        },
        {
          "id": 46231,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI to look for infarct</span></p>"
        },
        {
          "id": 46232,
          "text": "<p><span style=\"font-size:12.0pt;\">Tab labetalol 10 mg stat</span></p>"
        },
        {
          "id": 46233,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man suddenly developed right-sided weakness and aphasia within 2 hours. His BP recorded was 160/110 mmHg and NCCT was clear. What is the next step in management? (INICET MAY 2021)</span></p>",
      "unique_key": "Q1284812",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289605,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;D) Thrombolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">With a BP below 185/110 mmHg, clear NCCT, and symptoms within 4.5 hours, the patient qualifies for thrombolysis, the standard treatment for acute ischemic stroke to dissolve clots and restore blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If the blood pressure (BP) is more than or equal to 185/110 mmHg, administer IV labetalol to lower the BP to less than 185/110 mmHg before immediately proceeding with thrombolysis. CT angiography can be performed while thrombolysis is ongoing. Start the thrombolytic agent in the CT room and simultaneously inject a bolus of contrast for the CT angiogram to check for large vessel occlusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. CT angiography:&nbsp;</strong>CT angiography can be done simultaneously with thrombolysis but not instead of it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. MRI:&nbsp;</strong>MRI is not the immediate next step when NCCT is clear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Labetalol:&nbsp;</strong>Labetalol is used to lower BP but not the primary treatment in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">In acute ischemic stroke with BP &lt; 185/110 and clear NCCT, thrombolysis is the next step.</span></p>",
      "correct_choice_id": 46233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11305,
      "choices": [
        {
          "id": 45186,
          "text": "<p><span style=\"font-size:12.0pt;\">Give antibiotics and send the patient home</span></p>"
        },
        {
          "id": 45187,
          "text": "<p><span style=\"font-size:12.0pt;\">Admit to ICU without mechanical ventilation</span></p>"
        },
        {
          "id": 45188,
          "text": "<p><span style=\"font-size:12.0pt;\">Admit to ICU with invasive mechanical ventilation</span></p>"
        },
        {
          "id": 45189,
          "text": "<p><span style=\"font-size:12.0pt;\">Consider admission in a non-ICU setting</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old man presents with a cough with yellowish sputum. Auscultation revealed bronchial breath sounds. He is hemodynamically stable and not confused. On examination, his respiratory rate is 20/min and blood pressure is 110/70 mmHg. Lab reports show urea levels of 44 mg/dL. What is the next best step in the management of this patient?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q3779065",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289606,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Consider admission in a non-ICU setting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation suggests a lower respiratory tract infection, likely pneumonia, given the cough with yellow sputum and bronchial breath sounds on auscultation. The management decision can be guided by the <strong>CURB-65 score</strong>, which helps determine the severity of pneumonia and the need for hospitalization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CURB-65 score components are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>C</strong>onfusion: No</span></li><li><span style=\"font-size:12.0pt;\"><strong>U</strong>rea &gt; 7 mmol/L (19 mg/dL): Yes (urea is 44 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\"><strong>R</strong>espiratory rate ≥ 30/min: No (respiratory rate is 20/min)</span></li><li><span style=\"font-size:12.0pt;\"><strong>B</strong>lood pressure (systolic &lt; 90 mmHg or diastolic ≤ 60 mmHg): No (BP is 110/70 mmHg)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Age ≥ 65 years</strong>: Yes (patient is 68 years old)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has two points (urea &gt; 19 mg/dL and age ≥ 65 years).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the CURB-65 score:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>0 points</strong>: Outpatient treatment</span></li><li><span style=\"font-size:12.0pt;\"><strong>1 point</strong>: Consider outpatient treatment or short inpatient stay</span></li><li><span style=\"font-size:12.0pt;\"><strong>2 points</strong>: Inpatient treatment</span></li><li><span style=\"font-size:12.0pt;\"><strong>3-5 points</strong>: Consider ICU admission</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient scores 2 points, indicating the need for inpatient treatment but not necessarily in the ICU.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Give antibiotics and send the patient home:</strong> This would be appropriate for a patient with a CURB-65 score of 0 or possibly 1, but not for a score of 2, which indicates a higher risk that necessitates closer monitoring in an inpatient setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Admit to ICU without mechanical ventilation:</strong> ICU admission is generally reserved for patients with a CURB-65 score of 3 or higher, indicating severe pneumonia. This patient's condition does not meet those criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Admit to ICU with invasive mechanical ventilation:</strong> This is appropriate for patients with very severe pneumonia (CURB-65 score of 4-5) or those in respiratory distress, neither of which applies to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients with pneumonia, the CURB-65 score is a useful tool for determining the appropriate level of care. A score of 2 typically indicates the need for inpatient treatment in a non-ICU setting.</span></p>",
      "correct_choice_id": 45189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11974,
      "choices": [
        {
          "id": 47861,
          "text": "<p><span style=\"font-size:12.0pt;\">Peritoneal Biopsy</span></p>"
        },
        {
          "id": 47862,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT</span></p>"
        },
        {
          "id": 47863,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation</span></p>"
        },
        {
          "id": 47864,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with cough, cold, fever, and malaise associated with weight loss and ascites. The patient does not have any evidence of cirrhosis and her coagulation profile is normal. Ascitic fluid analysis showed elevated adenosine deaminase. What can be done next? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5073104",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289607,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Start ATT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In countries with a high prevalence of tuberculosis, such as India, the presence of elevated adenosine deaminase (ADA) in ascitic fluid is highly suggestive of abdominal tuberculosis (TB). ADA is a useful diagnostic marker for TB, particularly when its levels are significantly elevated (e.g., above 39 IU/L). Given the clinical context of weight loss, fever, and ascites, along with a high ADA level, it is reasonable to initiate anti-tubercular therapy (ATT) without further invasive testing. Starting ATT and monitoring the patient's response is an effective and practical approach, especially in resource-limited settings. This strategy avoids unnecessary invasive procedures like peritoneal biopsy, which should be reserved for cases where there is doubt about the diagnosis or if the patient does not respond to initial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Peritoneal Biopsy:</strong> While peritoneal biopsy is the gold standard for diagnosing peritoneal TB, it is invasive and resource-intensive. In high-prevalence areas, where elevated ADA levels strongly suggest TB, initiating ATT is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Observation:</strong> Given the significant clinical symptoms and elevated ADA levels, mere observation is not appropriate. Delay in treatment could lead to worsening of the patient’s condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laparotomy:</strong> Laparotomy is an invasive surgical procedure and is not warranted for diagnosing TB when non-invasive methods like ADA testing and clinical presentation strongly suggest the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-prevalence countries for tuberculosis, elevated adenosine deaminase (ADA) in ascitic fluid, along with clinical signs, is sufficient to start anti-tubercular therapy (ATT) without the need for invasive procedures.</span></p>",
      "correct_choice_id": 47862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20268,
      "choices": [
        {
          "id": 81033,
          "text": "<p><span style=\"font-size:12.0pt;\">Extradural cord compression</span></p>"
        },
        {
          "id": 81034,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyotrophic lateral sclerosis</span></p>"
        },
        {
          "id": 81035,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        },
        {
          "id": 81036,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute combined degeneration of the cord</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male patient presents with sensory loss and weakness of limbs for 3 months. He also has angular stomatitis. On examination, there is loss of proprioception, vibration sensations, UMN type of lower limb weakness, and absent ankle reflex. What is the most probable diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q7320906",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289608,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Subacute combined degeneration of the cord</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with sensory loss, limb weakness, and specific neurological findings that are indicative of subacute combined degeneration of the cord due to vitamin B12 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Findings:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Sensory Loss and Weakness of Limbs:</strong> This suggests a neurological disorder affecting the peripheral and central nervous systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angular Stomatitis:</strong> This is often associated with vitamin deficiencies, particularly vitamin B12.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Loss of Proprioception and Vibration Sensation:</strong> This is characteristic of posterior column involvement, which is seen in subacute combined degeneration.</span></li><li><span style=\"font-size:12.0pt;\"><strong>UMN Type of Lower Limb Weakness:</strong> Upper motor neuron signs (UMN) such as spasticity and exaggerated reflexes, except for the absent ankle reflex, are indicative of corticospinal tract involvement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Absent Ankle Reflex:</strong> This, along with UMN signs, is a classic feature of subacute combined degeneration of the cord.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Subacute Combined Degeneration of the Cord:</strong> This condition is due to vitamin B12 deficiency, leading to demyelination of the posterior columns and corticospinal tracts. This results in a combination of sensory ataxia, spasticity, and other upper motor neuron signs, except for the absent ankle reflex which indicates peripheral neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Findings:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Angular Stomatitis:</strong> Points towards a vitamin deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Babinski Positivity with Absent Ankle Jerk:</strong> This combination is specifically associated with subacute combined degeneration of the cord due to B12 deficiency. Other conditions like cauda equina syndrome or Friedreich ataxia could present similarly, but the presence of angular stomatitis and the described neurological findings strongly support subacute combined degeneration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Extradural Cord Compression:</strong> This would typically present with radicular pain and possibly more pronounced lower motor neuron signs below the level of compression, not the UMN signs described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amyotrophic Lateral Sclerosis (ALS):</strong> ALS involves both UMN and LMN signs but does not typically present with sensory loss or specific vitamin deficiency signs like angular stomatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Multiple Sclerosis (MS):</strong> MS can present with varied neurological signs, but it does not typically present with angular stomatitis or the classic combination of absent ankle reflex with UMN signs seen in subacute combined degeneration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subacute combined degeneration of the cord due to vitamin B12 deficiency presents with sensory loss, UMN signs in the lower limbs, and absent ankle reflex, along with other signs of vitamin deficiency like angular stomatitis.</span></p>",
      "correct_choice_id": 81036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11204,
      "choices": [
        {
          "id": 44782,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous nodules</span></p>"
        },
        {
          "id": 44783,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren's syndrome</span></p>"
        },
        {
          "id": 44784,
          "text": "<p><span style=\"font-size:12.0pt;\">Felty's syndrome</span></p>"
        },
        {
          "id": 44785,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasculitis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the most common extra-articular manifestation of rheumatoid arthritis? (NEET PG 2018)</span></p>",
      "unique_key": "Q6009017",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289609,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Subcutaneous nodules</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subcutaneous nodules are the most common extra-articular manifestation of rheumatoid arthritis (RA), occurring in 20-30% of cases, usually in seropositive patients. These nodules often appear on extensor surfaces, such as the elbows, or in other areas subject to pressure, and they can also manifest in internal organs like the lungs and heart. Their presence correlates with a more severe disease course and is associated with specific RA antibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sjogren's syndrome:&nbsp;</strong>While Sjogren's syndrome (secondary to RA) can occur and manifests as keratoconjunctivitis sicca, it is less common than subcutaneous nodules as an extra-articular feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Felty's syndrome:&nbsp;</strong>This is a rare complication of long-standing RA, characterized by neutropenia and splenomegaly, and occurs in about 1% of patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vasculitis:&nbsp;</strong>Cutaneous vasculitis may present in RA but is less frequently observed compared to subcutaneous nodules. It includes symptoms like ulcers and purpura.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/organ-involved.jpg\" alt=\"\" width=\"1000\" height=\"1124\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Additional Information&nbsp;Deformities</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Pseudo Deformities</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163519.jpg\" alt=\"\" width=\"1000\" height=\"222\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. True Deformities</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163628.jpg\" alt=\"\" width=\"1000\" height=\"672\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Pocket Medicine 8E/2022</strong></span></p>",
      "correct_choice_id": 44782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47516,
      "choices": [
        {
          "id": 189675,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        },
        {
          "id": 189676,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 189677,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 189678,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male patient presents with difficulty in breathing and dizziness. He has been undergoing treatment for lung cancer. On examination, breath sounds were reduced over the left inferior-scapular region. What is the likely diagnosis? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q3713337",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289610,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cardiac tamponade</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The key clues in this scenario include the patient’s history of lung cancer and the reduction in breath sounds over the left inferior-scapular region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lung cancer is a significant cause of cardiac tamponade due to its potential to invade the pericardium and cause pericardial effusion. Cardiac tamponade occurs when fluid accumulates in the pericardial sac, leading to increased pressure on the heart, impairing its ability to pump effectively, and often resulting in symptoms such as difficulty breathing and dizziness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient’s symptoms and history suggest that the lung cancer has likely caused a large pericardial effusion, leading to cardiac tamponade. The reduction in breath sounds over the left inferior-scapular region is consistent with this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EWOT sign – In a patient with large pericardial effusion, probably a cardiac tamponade with &nbsp;reduced breath sounds over the left infrascapular region <u>+</u> added sounds like bronchophony, egophony, bronchial breath sounds, is referred as EWOT sign</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pleural effusion:&nbsp;</strong>While lung cancer can also cause pleural effusion, the question's clinical senario and reduction in breath sounds align more closely with cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pneumothorax:&nbsp;</strong>Pneumothorax typically presents with sudden chest pain and shortness of breath, and the physical examination would usually reveal hyperresonance and decreased breath sounds on one side. It does not fit the patient's history of lung cancer and the described examination findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Constrictive pericarditis:&nbsp;</strong>This condition involves chronic inflammation and thickening of the pericardium, leading to impaired filling of the heart. It is less likely given the acute presentation and the specific mention of lung cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lung cancer can lead to cardiac tamponade, a life-threatening condition characterized by the accumulation of fluid in the pericardial sac, impairing the heart's function and causing symptoms such as difficulty breathing and dizziness.</span></p>",
      "correct_choice_id": 189676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24774,
      "choices": [
        {
          "id": 99057,
          "text": "<p><span style=\"font-size:11.0pt;\">Obesity hypoventilation syndrome</span></p>"
        },
        {
          "id": 99058,
          "text": "<p><span style=\"font-size:11.0pt;\">Obstructive sleep apnea</span></p>"
        },
        {
          "id": 99059,
          "text": "<p><span style=\"font-size:11.0pt;\">Central sleep apnea</span></p>"
        },
        {
          "id": 99060,
          "text": "<p><span style=\"font-size:11.0pt;\">Narcolepsy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A female presented with excessive daytime sleepiness and impaired concentration and memory for one year. On examination the BMI was 43 kg/m² and BP was 170/98 mmHg. ABG was done in awake state and the findings are given below. Which of the following is the likely diagnosis? PaO2: 70 mmHg PaCO2: 53 mmHg HCO3: 33 mmHg. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9899699",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289611,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Obesity hypoventilation syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Obesity hypoventilation syndrome (OHS), </strong>also known as Pickwickian syndrome, is characterized by obesity (BMI &gt;30 kg/m²), hypoventilation (PaCO2 &gt;45 mmHg), and lack of significant underlying lung disease. The ABG findings showing hypercapnia (high PaCO2) and hypoxemia (low PaO2) in the awake state are indicative of OHS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Obstructive sleep apnea:</strong> Occurs during sleep, not necessarily presenting with hypercapnia in the awake state.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Central sleep apnea:</strong> Characterized by pauses in breathing during sleep without the obesity-related hypoventilation.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Narcolepsy:</strong> Does not typically present with ABG abnormalities or obesity hypoventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obesity hypoventilation syndrome involves obesity, chronic hypercapnia, and hypoxemia, primarily in the awake state.</span></p>",
      "correct_choice_id": 99057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11248,
      "choices": [
        {
          "id": 44958,
          "text": "<p><span style=\"font-size:12.0pt;\">Components of MELD (Model for end stage liver disease) scoring system are creatinine, bilirubin, INR, serum sodium (mEq/L).</span></p>"
        },
        {
          "id": 44959,
          "text": "<p><span style=\"font-size:12.0pt;\">Components of CTP (Child Turcotte Pugh) score are albumin, bilirubin, INR, ascites, encephalopathy.</span></p>"
        },
        {
          "id": 44960,
          "text": "<p><span style=\"font-size:12.0pt;\">Components of CTP (Child Turcotte Pugh) are creatinine, bilirubin, and INR.</span></p>"
        },
        {
          "id": 44961,
          "text": "<p><span style=\"font-size:12.0pt;\">MELD score is used to assess and prioritize patients awaiting liver transplantation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is false? (NEET PG 2019)</span></p>",
      "unique_key": "Q4945272",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289612,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Components of CTP (Child Turcotte Pugh) are creatinine, bilirubin, and INR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Statement C is false. The Child Turcotte Pugh (CTP) score does not include creatinine as a component. Instead, CTP uses the following parameters to assess the severity of liver disease: bilirubin, albumin, INR, ascites, and encephalopathy. This score is traditionally used to evaluate the prognosis in chronic liver disease, primarily cirrhosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Components of MELD scoring system are creatinine, bilirubin, INR, serum sodium (mEq/L):</strong> This statement is true. The MELD score has been updated to include serum sodium along with creatinine, bilirubin, and INR to improve its accuracy in predicting mortality risk in liver transplant candidates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Components of CTP score are albumin, bilirubin, INR, ascites, encephalopathy:</strong> This is accurate and reflects the correct components of the CTP score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MELD score is used to assess and prioritize patients awaiting liver transplantation:</strong> This is true. The MELD score is widely used to prioritize patients for liver transplantation based on their risk of death from liver disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MELD-Na components mnemonic “<i><strong>CBI”</strong></i></span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>C - C</strong></span><span style=\"font-size:12.0pt;\">reatinine</span></p><p><span style=\"color:red;font-size:12.0pt;\"><strong>B - B</strong></span><span style=\"font-size:12.0pt;\">ilirubin</span></p><p><span style=\"color:red;font-size:12.0pt;\"><strong>I - I</strong></span><span style=\"font-size:12.0pt;\">NR + Sodium</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CTP score mnemonic </span><span style=\"color:red;font-size:12.0pt;\"><i><strong>BANANa</strong></i></span></p><p>&nbsp;</p><ul><li><span style=\"color:red;font-size:12.0pt;\"><strong>B</strong></span><span style=\"font-size:12.0pt;\">ilirubin </span><span style=\"color:red;font-size:12.0pt;\"><strong>A</strong></span><span style=\"font-size:12.0pt;\">lbumin I</span><span style=\"color:red;font-size:12.0pt;\"><strong>N</strong></span><span style=\"font-size:12.0pt;\">R </span><span style=\"color:red;font-size:12.0pt;\"><strong>A</strong></span><span style=\"font-size:12.0pt;\">scites e</span><span style=\"color:red;font-size:12.0pt;\"><strong>N</strong></span><span style=\"font-size:12.0pt;\">cephalopathy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cirrhosis/Chap 344</strong></span></p>",
      "correct_choice_id": 44960,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11601,
      "choices": [
        {
          "id": 46370,
          "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
        },
        {
          "id": 46371,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary arteriovenous fistula</span></p>"
        },
        {
          "id": 46372,
          "text": "<p><span style=\"font-size:12.0pt;\">High altitude</span></p>"
        },
        {
          "id": 46373,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothermia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cause of central cyanosis?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q4343541",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypothermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cyanosis occurs when there is a significant amount of deoxygenated hemoglobin in the blood, typically due to issues with oxygenation or hemoglobin abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, <strong>hypothermia</strong> leads to <strong>peripheral cyanosis</strong>, not central cyanosis. In hypothermia, the blood flow is sluggish due to vasoconstriction, particularly in the extremities, which results in a bluish discoloration of the skin. However, the central organs typically remain oxygenated.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cyanosis can be caused by several factors:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Methemoglobinemia</strong>: This condition involves the presence of methemoglobin in the blood, which does not carry oxygen effectively, leading to central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pulmonary Arteriovenous Fistula</strong>: This abnormal connection between an artery and a vein in the lungs allows blood to bypass the alveoli, leading to poorly oxygenated blood entering the systemic circulation, causing central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. High Altitude</strong>: At high altitudes, the reduced atmospheric pressure leads to lower oxygen availability, causing hypoxemia and central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothermia causes only peripheral cyanosis due to sluggish blood flow, not central cyanosis</span></p>",
      "correct_choice_id": 46373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54291,
      "choices": [
        {
          "id": 216633,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b</span></p>"
        },
        {
          "id": 216634,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c</span></p>"
        },
        {
          "id": 216635,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 216636,
          "text": "<p><span style=\"font-size:12.0pt;\">Only b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin is secreted by which of the following?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Liver</span><br><span style=\"font-size:12.0pt;\">b. Kidney</span><br><span style=\"font-size:12.0pt;\">c. Spleen</span><br><span style=\"font-size:12.0pt;\">d. Heart</span></p>",
      "unique_key": "Q5540668",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin (EPO) is a hormone responsible for stimulating the production of red blood cells in the bone marrow. The primary source of erythropoietin in the human body is the kidney, which accounts for about 90% of its production. The liver contributes approximately 10% of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Liver:</strong> The liver produces erythropoietin mainly during fetal development, and its contribution decreases postnatally, although it continues to produce a small amount in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Kidney:</strong> Erythropoietin is mainly produced by <strong>interstitial fibroblast-like cells located in the renal cortex, particularly near the proximal convoluted tubules.</strong> The production of EPO in the kidneys is primarily regulated by oxygen levels; hypoxia (low oxygen levels) stimulates its secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spleen and heart are not known sources of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option c &amp; d:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Neither the spleen nor the heart produce erythropoietin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin is primarily produced by the kidneys (90%) and to a lesser extent by the liver (10%). These organs are the main sources of erythropoietin in the human body, with the kidneys playing a dominant role in its regulation and production in response to hypoxia.</span></p>",
      "correct_choice_id": 216633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11277,
      "choices": [
        {
          "id": 45074,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluent aphasia</span></p>"
        },
        {
          "id": 45075,
          "text": "<p><span style=\"font-size:12.0pt;\">Non fluent</span></p>"
        },
        {
          "id": 45076,
          "text": "<p><span style=\"font-size:12.0pt;\">Anomic</span></p>"
        },
        {
          "id": 45077,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of aphasia is seen in the lesions of the posterior part of the superior temporal gyrus? (NEET PG 2020)</span></p>",
      "unique_key": "Q8309866",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289615,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Fluent aphasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The posterior part of the superior temporal gyrus is where Wernicke's area is located, which is crucial for language comprehension. Lesions in this area lead to Wernicke's aphasia, which is a type of fluent aphasia. Patients with this type of aphasia exhibit fluent but often meaningless speech and have significant difficulties in understanding spoken language. Their speech is typically characterized by normal flow and articulation but includes nonsensical phrases and incorrect word substitutions (neologisms).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Non-fluent aphasia:&nbsp;</strong>This type of aphasia, typically associated with damage to Broca’s area in the frontal lobe, results in slow, labored speech and struggle in forming words, though comprehension often remains intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anomic aphasia:&nbsp;</strong>In anomic aphasia, the person can speak fluently and understand speech but has difficulty naming objects and words, typically not linked to damage in the superior temporal gyrus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Conduction aphasia:&nbsp;</strong>This arises from damage to the arcuate fasciculus, the brain structure that connects Wernicke's area to Broca’s area. It is characterized by fluent speech with frequent errors, good comprehension, but poor repetition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Regions anterior to the central sulcus are motor areas and posterior are sensory areas. Hence temporal gyrus involvement causes a fluent aphasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-110907.jpg\" alt=\"\" width=\"1000\" height=\"495\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - KV Krishna Das textbook of Medicine 5th edition</strong></span></p>",
      "correct_choice_id": 45074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47635,
      "choices": [
        {
          "id": 190151,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener's syndrome</span></p>"
        },
        {
          "id": 190152,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 190153,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucoviscidosis</span></p>"
        },
        {
          "id": 190154,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old male presented with infertility, and he has chronic sinusitis, bronchiectasis, and situs inversus. What is the likely disorder?</span></p>",
      "unique_key": "Q1231760",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289616,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kartagener's syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener's syndrome, a subset of primary ciliary dyskinesia, is characterized by the triad of chronic sinusitis, bronchiectasis, and situs inversus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infertility in males is also a common feature due to the dysfunction of cilia and flagella, leading to impaired sperm motility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Situs inversus is a condition where the major visceral organs are mirrored from their normal positions, often seen in Kartagener's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cystic fibrosis</strong>: While patients with cystic fibrosis may also present with sinusitis, infertility, and bronchiectasis, they do not typically have situs inversus, which is specific to Kartagener's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mucoviscidosis</strong>: This is another term for cystic fibrosis, and thus the same reasoning applies as above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Klinefelter syndrome</strong>: This genetic disorder can present with infertility but does not include chronic sinusitis, bronchiectasis, or situs inversus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener's syndrome is characterized by the triad of chronic sinusitis, bronchiectasis, and situs inversus, and is associated with infertility in males due to primary ciliary dyskinesia.</span></p>",
      "correct_choice_id": 190151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66643,
      "choices": [
        {
          "id": 265713,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic shock</span></p>"
        },
        {
          "id": 265714,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiogenic shock</span></p>"
        },
        {
          "id": 265715,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurogenic shock</span></p>"
        },
        {
          "id": 265716,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaphylactic shock</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient after road traffic accident was brought to the emergency. His pulse rate was 130 beats per minute, blood pressure was 80/60 mm of Hg. He had multiple linear wheals over the body, and complained of difficulty in breathing. He mentioned hitting a beehive during the accident. On evaluation his ECG was normal, eFAST was negative, and chest X-ray was normal. This status of the patient could be best classified under which type of shock? [Twisted PYQ]</span></p>",
      "unique_key": "Q6495167",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Anaphylactic shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anaphylactic shock is a type of distributive shock resulting from a severe allergic reaction, in this case to bee stings. The clinical presentation includes:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Tachycardia (130 bpm)</span></li><li><span style=\"font-size:12.0pt;\">Hypotension (80/60 mmHg)</span></li><li><span style=\"font-size:12.0pt;\">Urticaria (linear wheals)</span></li><li><span style=\"font-size:12.0pt;\">Respiratory symptoms (difficulty breathing)</span></li><li><span style=\"font-size:12.0pt;\">Clear history of allergen exposure (beehive)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemorrhagic shock</strong>: Though tachycardia and hypotension are present, the normal eFAST and absence of obvious bleeding sources make this unlikely. The presence of urticaria and respiratory symptoms point towards a different etiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardiogenic shock</strong>: Normal ECG findings make this unlikely. Additionally, the presence of systemic symptoms like urticaria suggests a different pathophysiology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Neurogenic shock</strong>: Typically presents with bradycardia due to unopposed vagal tone, not tachycardia as seen in this case. Also, neurogenic shock doesn't cause urticaria or respiratory symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anaphylactic shock should be suspected when patients present with:</span></p><ol><li><span style=\"font-size:12.0pt;\">Sudden onset of systemic symptoms</span></li><li><span style=\"font-size:12.0pt;\">Clear exposure to a potential allergen</span></li><li><span style=\"font-size:12.0pt;\">Classic triad of hypotension, urticaria, and respiratory symptoms</span></li><li><span style=\"font-size:12.0pt;\">Tachycardia as a compensatory mechanism</span></li></ol>",
      "correct_choice_id": 265716,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11445,
      "choices": [
        {
          "id": 45746,
          "text": "<p><span style=\"font-size:12.0pt;\">Pott's Spine</span></p>"
        },
        {
          "id": 45747,
          "text": "<p><span style=\"font-size:12.0pt;\">Guillain Barre Syndrome</span></p>"
        },
        {
          "id": 45748,
          "text": "<p><span style=\"font-size:12.0pt;\">Cauda Equina Syndrome</span></p>"
        },
        {
          "id": 45749,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple Sclerosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with a history of a backache for 10 days, has now presented with difficulty in micturition and defecation. There was no history of a cough or fever previously. What is the diagnosis? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5906544",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289618,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Cauda-Equina syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spinal cord ends at L1.&nbsp;</strong>Hence to accommodate the mismatch between vertebra and cord, the conus is formed from T12-L2 vertebral level housing the sacral portion of the cord. The lumbosacral roots descend downwards from conus and exit the corresponding foramina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sacral (S2,3,4) are responsible for sensations of the bladder wall. Hence injury leads to absent sensation and bladder distension with dribbling of urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong>&nbsp;<strong>A. Pott's Spine:</strong> Incorrect because Pott's disease (tuberculosis of the spine) typically presents with chronic back pain associated with systemic symptoms like fever, night sweats, and weight loss due to the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Guillain Barre Syndrome:</strong> Guillain Barre Syndrome primarily presents with ascending paralysis starting from the feet upwards, and sphincter involvement is rare, especially as an initial symptom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Multiple Sclerosis:</strong> Incorrect because Multiple Sclerosis involves demyelination primarily affecting the brain and spinal cord but typically causes chronic, rather than acute, symptoms, and would not likely present with acute bladder and bowel dysfunction without other neurological signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cauda Equina Syndrome presents with acute lower back pain and severe disturbances in bladder and bowel control due to compression of the nerve roots in the lumbar and sacral areas, requiring urgent medical attention to prevent permanent damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Neurology/Diseases of spinal Cord/Chap 442</strong></span></p>",
      "correct_choice_id": 45748,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20256,
      "choices": [
        {
          "id": 80985,
          "text": "<p><span style=\"font-size:12.0pt;\">Bumetanide</span></p>"
        },
        {
          "id": 80986,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethacrynic acid</span></p>"
        },
        {
          "id": 80987,
          "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide</span></p>"
        },
        {
          "id": 80988,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with hyperkalemia and elevated urea levels underwent dialysis. Towards the end of the session, she became drowsy and had a sudden seizure episode. On examination, the patient was hypotensive. What is the treatment for this condition? (NEET PG 2023)</span></p>",
      "unique_key": "Q1882201",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289619,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D. Mannitol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is experiencing <strong>Dialysis Disequilibrium Syndrome (DDS</strong>), a complication that can occur during or after hemodialysis, especially in patients with <strong>initially very high urea levels</strong> undergoing dialysis for the first time. DDS is caused by a rapid decrease in urea levels in the blood, leading to a sudden change in osmolarity, which causes water to move into the cells, resulting in cerebral edema and neurological symptoms such as drowsiness and seizures.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Dialysis Disequilibrium Syndrome (DDS):</strong> This condition is characterized by neurological symptoms due to cerebral edema caused by rapid changes in blood urea levels during dialysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mannitol:</strong> This osmotic diuretic is used to treat cerebral edema by reducing intracranial pressure and drawing fluid out of the brain cells, thus decreasing cerebral edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bumetanide:</strong> This loop diuretic is used for fluid overload but not specifically indicated for treating cerebral edema in DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ethacrynic acid:</strong> Another loop diuretic, similar to bumetanide, and not used for DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nesiritide:</strong> A recombinant form of B-type natriuretic peptide used in acute heart failure, not for treating DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment for Dialysis Disequilibrium Syndrome (DDS), which can occur during or after dialysis, involves reducing cerebral edema. The first-line treatment is mannitol, an osmotic diuretic.</span></p>",
      "correct_choice_id": 80988,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55394,
      "choices": [
        {
          "id": 221037,
          "text": "<p><span style=\"font-size:12pt;\">Filtration fraction</span></p>"
        },
        {
          "id": 221038,
          "text": "<p><span style=\"font-size:12pt;\">Tubular secretion</span></p>"
        },
        {
          "id": 221039,
          "text": "<p><span style=\"font-size:12pt;\">Tubular reabsorption</span></p>"
        },
        {
          "id": 221040,
          "text": "<p><span style=\"font-size:12pt;\">Clearance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What renal function does the formula UV/P represent? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5881707",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289620,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Clearance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Renal clearance is a measure of the volume of plasma from which a substance is completely removed by the kidneys per unit time. It provides important information about the efficiency with which the kidneys can filter out a substance from the bloodstream and excrete it in the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The formula is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clearance(C) = UV /P ​</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Where:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">C is the clearance of the substance.</span></li><li><span style=\"font-size:12pt;\">U is the concentration of the substance in the urine.</span></li><li><span style=\"font-size:12pt;\">V is the urine flow rate (volume of urine produced per unit time).</span></li><li><span style=\"font-size:12pt;\">P is the concentration of the substance in the plasma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Filtration fraction:</strong> This is the ratio of the glomerular filtration rate (GFR) to the renal plasma flow (RPF).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tubular secretion:</strong> This refers to the active process by which substances are transported from the blood into the renal tubule. While clearance can involve secretion, the formula UV/P specifically calculates overall clearance, not just secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tubular reabsorption:</strong> This refers to the process by which substances are reabsorbed from the renal tubule back into the blood. The UV/P formula does not directly represent reabsorption but overall clearance, which can include filtration and reabsorption processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The formula UV/P is used to calculate the renal clearance of a substance, reflecting the volume of plasma from which the kidneys can completely remove that substance per unit time.</span></p>",
      "correct_choice_id": 221040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11351,
      "choices": [
        {
          "id": 45370,
          "text": "<p><span style=\"font-size:12.0pt;\">STEMI</span></p>"
        },
        {
          "id": 45371,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 45372,
          "text": "<p><span style=\"font-size:12.0pt;\">Stable Angina</span></p>"
        },
        {
          "id": 45373,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 NTG tablets with no relief. His vitals are stable and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis? (Neet pg 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191548.jpg\" alt=\"\" width=\"500\" height=\"268\"></p>",
      "unique_key": "Q4369885",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289621,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Unstable Angina</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient's presentation includes chest pain unrelieved by nitroglycerin (NTG), stable vitals, and normal cardiac enzymes. The provided ECG is normal, showing no signs of ST elevation or ischemic changes such as ST depression or T wave inversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Unstable Angina</strong> involves chest pain at rest or with minimal exertion, and normal cardiac enzymes. The patient has multiple risk factors (dyslipidemia, hypertension, aortic sclerosis), and the fact that his chest pain did not respond to NTG and his enzymes are normal strongly suggests unstable angina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. STEMI: </strong>STEMI is characterized by ST elevation on ECG and elevated cardiac enzymes indicating myocardial necrosis. This patient's ECG shows no ST elevation, and his cardiac enzymes are normal, making STEMI unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NSTEMI: </strong>NSTEMI would present with elevated cardiac enzymes due to myocardial damage, despite the absence of ST elevation. This patient’s normal enzyme levels exclude NSTEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stable Angina: </strong>Stable angina presents with chest pain that is typically relieved by rest or nitroglycerin. The patient’s chest pain persisted despite taking NTG, indicating that stable angina is not the correct diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unstable angina is characterized by chest pain that occurs at rest or with minimal exertion, does not respond to nitroglycerin, and is associated with normal cardiac enzyme levels.</span></p>",
      "correct_choice_id": 45373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11723,
      "choices": [
        {
          "id": 46858,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytomegalovirus</span></p>"
        },
        {
          "id": 46859,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus</span></p>"
        },
        {
          "id": 46860,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella zoster virus</span></p>"
        },
        {
          "id": 46861,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of infection post-solid organ transplantation in an Indian setting? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8852149",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289622,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Cytomegalovirus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV is most common infection occurring after transplant. Risk depends on induction agent and seropositivity status. Minimal risk for D-/R-(Donor, recipient negative). Highest risk of reactivation in D-/R+ and patients who received anti-lymphocyte therapy. Prophylaxis is given pre-emptively if periodic CMV-DNA PCR are &gt;500 copies/ml with Valgan/ Foscarnet/Cidofovir. Letermovir has no hepato/nephrotoxicity (Safest)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">D-/R- patients should receive leucodepleted blood products to minimise transmission of CMV</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>EBV infection occurs in 1-2% of post-transplant patients and responds well to acyclovir prophylaxis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>VZV reactivation can occur at any point post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>HSV occurs within 1-month post-transplant in the absence of acyclovir prophylaxis&nbsp;Nephrology/infectious diseases/post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is the most prevalent and clinically significant viral infection in the post-solid organ transplant setting in India, necessitating targeted prophylaxis and monitoring protocols to mitigate its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Critical Care Nephrology /Chapter 95</strong></span></p>",
      "correct_choice_id": 46858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50949,
      "choices": [
        {
          "id": 203337,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hyperventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203338,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis, hypoventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203339,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hypoventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203340,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hypoventilation, adequate metabolic compensation&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old with a history of COPD is brought to the ER with worsening dyspnea. ABG was done and pH was 7.3, pCO2 was 60 mmHg with HCO3- being 28 mEq/L. Which of the following is seen in this patient? (</span>INICET Nov 2023)</p>",
      "unique_key": "Q8761970",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289623,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Respiratory acidosis, hypoventilation, inadequate metabolic compensation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's arterial blood gas (ABG) shows a pH of 7.3, indicating acidosis (normal pH: 7.35-7.45). The elevated pCO2 of 60 mmHg (normal: 35-45 mmHg) points to a respiratory cause of the acidosis, specifically respiratory acidosis. In COPD patients, chronic CO2 retention is common, leading to increased bicarbonate (HCO3-) levels as a compensatory mechanism. However, in acute respiratory acidosis, the metabolic compensation is typically inadequate, as seen by the HCO3- level of 28 mEq/L (normal: 22-28 mEq/L). The inadequate compensation suggests an acute exacerbation rather than a chronic condition, as chronic respiratory acidosis would have a more elevated bicarbonate level (&gt;30 mEq/L).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Respiratory acidosis, hyperventilation, inadequate</strong> <strong>metabolic compensation:</strong> Hyperventilation leads to respiratory alkalosis, not acidosis. The patient's presentation does not fit this scenario.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Respiratory alkalosis, hypoventilation, inadequate metabolic compensation:</strong>&nbsp;Hypoventilation causes respiratory acidosis, not alkalosis. This choice is incorrect.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory acidosis, hypoventilation, adequate metabolic compensation:&nbsp;</strong>Adequate metabolic compensation would show higher bicarbonate levels (&gt;30 mEq/L). The patient's bicarbonate level indicates inadequate compensation, ruling out this option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In acute respiratory acidosis due to COPD exacerbation, expect hypoventilation and inadequate metabolic compensation, indicated by elevated pCO2 and only slightly elevated HCO3- levels.</span></p>",
      "correct_choice_id": 203339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11515,
      "choices": [
        {
          "id": 46026,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 46027,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptokinase</span></p>"
        },
        {
          "id": 46028,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 46029,
          "text": "<p><span style=\"font-size:12.0pt;\">Prasugrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient with non-ST-elevation myocardial infarction (NSTEMI). All the following can be used for treatment except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q4390074",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289624,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Streptokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of NSTEMI, the focus is on antiplatelet and anticoagulant therapy rather than fibrinolytic agents like streptokinase. Streptokinase is specifically used in the treatment of ST-elevation myocardial infarction (STEMI) where there is a fibrin-rich thrombus completely occluding a coronary artery. NSTEMI, in contrast, involves a partial occlusion by a platelet-rich thrombus, and fibrinolytics are generally not recommended because they are less effective and could potentially increase the risk of bleeding without significant benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspirin:&nbsp;</strong>As a foundational antiplatelet agent, aspirin is used in both STEMI and NSTEMI to reduce platelet aggregation and further thrombus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clopidogrel:&nbsp;</strong>This is another antiplatelet drug that is used in the management of both STEMI and NSTEMI as part of dual antiplatelet therapy (DAPT) along with aspirin to provide greater protection against thrombotic events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prasugrel:&nbsp;</strong>Similar to clopidogrel, prasugrel is used in acute coronary syndrome (ACS) management, including NSTEMI, especially when percutaneous coronary intervention (PCI) is planned, due to its potent antiplatelet effects. (Prasugrel is given peri-procedurally).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture40.jpg\" alt=\"\" width=\"1000\" height=\"697\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e chap 118/3518</strong></span></p>",
      "correct_choice_id": 46027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11568,
      "choices": [
        {
          "id": 46238,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4 correct</span></p>"
        },
        {
          "id": 46239,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 3 correct</span></p>"
        },
        {
          "id": 46240,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3 correct</span></p>"
        },
        {
          "id": 46241,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4 correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In atrial fibrillation, choose the correct statements: (INICET MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Novel oral anticoagulants (NOACs) used in the treatment of moderate to severe MS</span></li><li><span style=\"font-size:12.0pt;\">Anticoagulants should be given in patients with ischemic stroke due to atrial fibrillation</span></li><li><span style=\"font-size:12.0pt;\">NOACs are contraindicated in prosthetic valves</span></li><li><span style=\"font-size:12.0pt;\">All patients with atrial fibrillation who are not candidates for cardiac surgery can be started on beta-blockers</span></li></ol>",
      "unique_key": "Q3712308",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) 2 and 3 correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anticoagulants are indicated for ischemic stroke due to atrial fibrillation. NOACs are contraindicated in patients with prosthetic valves due to a lack of evidence on their efficacy and safety in this population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. NOACs are not used for moderate to severe mitral stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4. Beta-blockers or non-dihydropyridine calcium channel blockers are used for rate control but not universally applicable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Anticoagulants are used for ischemic stroke in AF, and NOACs are contraindicated in prosthetic valves.</span></p>",
      "correct_choice_id": 46240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11980,
      "choices": [
        {
          "id": 47885,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboxyhemoglobinemia</span></p>"
        },
        {
          "id": 47886,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 47887,
          "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
        },
        {
          "id": 47888,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfhemoglobinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the AIIMS emergency department with severe fatigue and prostration. She is a known case of chronic stable angina. While collecting a blood sample, you notice the blood has a brownish hue. What is the underlying diagnosis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5215309",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) Methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presenting with a brownish hue in the blood, coupled with a history of chronic stable angina, points towards methemoglobinemia. Patients with chronic stable angina are often on nitrate therapy, which is a known risk factor for developing methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methemoglobinemia occurs when the iron in hemoglobin is oxidized from the ferrous (Fe²⁺) state to the ferric (Fe³⁺) state, which is unable to bind oxygen effectively. This results in reduced oxygen delivery to tissues, leading to symptoms such as fatigue and cyanosis. The brownish hue of the blood, often described as chocolate-colored, is characteristic of methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carboxyhemoglobinemia:</strong> Carboxyhemoglobinemia is caused by carbon monoxide poisoning, typically associated with exposure to fire or automobile exhaust. The blood in this condition has a cherry red color, not brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sideroblastic anemia:</strong> Sideroblastic anemia is a form of anemia where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. It does not cause a brownish hue in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sulfhemoglobinemia:</strong> Sulfhemoglobinemia results from the incorporation of sulfur into hemoglobin, leading to a greenish or bluish color of the blood, rather than brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A brownish hue in the blood, especially in a patient on nitrate therapy, is indicative of methemoglobinemia, a condition where hemoglobin is oxidized, impairing its ability to carry oxygen effectively.</span></p>",
      "correct_choice_id": 47887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20269,
      "choices": [
        {
          "id": 81037,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral stenosis</span></p>"
        },
        {
          "id": 81038,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid stenosis</span></p>"
        },
        {
          "id": 81039,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 81040,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female patient came with complaints of chest pain, palpitation, and shortness of breath. On examination, a mid-diastolic murmur was heard, and a prominent 'a' wave was found on JVP. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q9216676",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289627,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Tricuspid stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of a mid-diastolic murmur and a prominent 'a' wave in the jugular venous pressure (JVP) are key indicators for diagnosing tricuspid stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tricuspid Stenosis</strong> causes an obstruction to right ventricular inflow, which leads to an increase in right atrial pressure, reflected as a prominent 'a' wave in the JVP. The mid-diastolic murmur is due to the turbulent flow across the narrowed tricuspid valve during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitral Stenosis:</strong> While it can cause a diastolic murmur, it typically does not cause a prominent 'a' wave in the JVP unless there is secondary pulmonary hypertension affecting the right side of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Regurgitation:</strong> This would cause a holosystolic murmur and, if severe enough to cause pulmonary hypertension, may indirectly cause changes in the JVP, but it does not directly cause a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid Regurgitation:</strong> This condition causes a large 'v' wave in the JVP due to backflow of blood into the right atrium during systole, not a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A prominent 'a' wave in JVP and a mid-diastolic murmur are indicative of tricuspid stenosis, a condition causing right ventricular inflow obstruction.</span></p>",
      "correct_choice_id": 81038,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66646,
      "choices": [
        {
          "id": 265725,
          "text": "<p><span style=\"font-size:12.0pt;\">Extradural hematoma</span></p>"
        },
        {
          "id": 265726,
          "text": "<p><span style=\"font-size:12.0pt;\">Subdural hematoma</span></p>"
        },
        {
          "id": 265727,
          "text": "<p><span style=\"font-size:12.0pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 265728,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraparenchymal hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents to the emergency department after falling from height. CT scan of the head is shown in the image. The CT finding is most suggestive of: [Twisted PYQ]</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_Gw1PL7s.png\" width=\"271\" height=\"330\"></span></p>",
      "unique_key": "Q5778377",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289628,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Extradural hematoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CT scan shows a hyperdense biconvex/lentiform collection adjacent to the inner table of the skull. This finding is characteristic of an extradural hematoma (EDH). The key features visible in this image are:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Lens/biconvex shaped hemorrhage</span></li><li><span style=\"font-size:12.0pt;\">Does not cross suture lines</span></li><li><span style=\"font-size:12.0pt;\">Well-defined margins</span></li><li><span style=\"font-size:12.0pt;\">Usually associated with skull fracture and middle meningeal artery injury</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subdural hematoma</strong>: Appears as a crescent-shaped hemorrhage that can cross suture lines, which is not seen in this image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subarachnoid hemorrhage</strong>: Appears as hyperdense blood following the brain sulci and cisterns, often described as a \"starry night\" appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intraparenchymal hemorrhage</strong>: Appears as a well-circumscribed hyperdense lesion within the brain tissue itself, often with surrounding edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Recognize the classic biconvex/lenticular shape of an extradural hematoma on CT</span></li><li><span style=\"font-size:12.0pt;\">Understand that EDH doesn't cross suture lines due to dural attachments</span></li><li><span style=\"font-size:12.0pt;\">Identify key differentiating features between various types of intracranial hemorrhages</span></li><li><span style=\"font-size:12.0pt;\">Appreciate the emergency nature of EDH as a neurosurgical emergency</span></li></ol>",
      "correct_choice_id": 265725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11205,
      "choices": [
        {
          "id": 44786,
          "text": "<p><span style=\"font-size:12.0pt;\">Agammaglobulinemia</span></p>"
        },
        {
          "id": 44787,
          "text": "<p><span style=\"font-size:12.0pt;\">Whipple's disease</span></p>"
        },
        {
          "id": 44788,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 44789,
          "text": "<p><span style=\"font-size:12.0pt;\">Crohn's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Periodic acid Schiff positive macrophages are seen in: (NEET PG 2018)</span></p>",
      "unique_key": "Q8888482",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289629,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Whipple's disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Periodic acid Schiff (PAS) positive macrophages are indicative of Whipple's disease, a rare bacterial infection that primarily affects the small intestine but can also impact other parts of the body like the heart, brain, and joints. PAS stains are used to identify polysaccharides, mucopolysaccharides, glycoproteins, and glycolipids in tissues. In Whipple's disease, PAS-positive macrophages in the small bowel biopsy are laden with Tropheryma whipplei bacteria, showing up as granular, magenta-colored inclusions in the cytoplasm of macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Agammaglobulinemia:&nbsp;</strong>This is an immunodeficiency disorder characterized by the absence of gamma globulins in the blood and a lack of mature B cells; it does not feature PAS-positive macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Abetalipoproteinemia:&nbsp;</strong>This is a disorder of lipid metabolism, leading to extremely low levels of cholesterol and triglycerides in the blood; it does not cause PAS-positive staining in macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Crohn's disease:&nbsp;</strong>An inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract, also not associated with PAS-positive macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PAS +ve macrophages are seen in:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Small bowel biopsy</strong> = Chronic Infection (E.g., Whipple’s disease, leishmaniasis, endemic mycoses).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Liver Biopsy:</strong> Alpha-1 antitrypsin deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bone Marrow:</strong> Disseminated infections vs Storage disorders (Niemann-Pick).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Malabsorption syndromes/Chap 176</strong></span></p>",
      "correct_choice_id": 44787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20258,
      "choices": [
        {
          "id": 80993,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 80994,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 80995,
          "text": "<p><span style=\"font-size:12.0pt;\">Esmolol</span></p>"
        },
        {
          "id": 80996,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents with severe restlessness, palpitations, and tremors to the emergency department. She is a known case of bronchial asthma. On examination, the neck looks swollen. Blood pressure is elevated, and tachycardia is noted. ECG shows atrial fibrillation. Which of the following drugs is used for immediate management in this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q1754187",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289631,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Diltiazem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with atrial fibrillation and bronchial asthma, the primary goal is to control the heart rate. For rate control in atrial fibrillation, beta-blockers and non-dihydropyridine calcium channel blockers (NDCCBs) like diltiazem or verapamil are commonly used. However, in this case, the patient has bronchial asthma, which makes the use of beta-blockers (such as propranolol and esmolol) less suitable due to their potential to exacerbate asthma symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diltiazem is a non-dihydropyridine calcium channel blocker that effectively controls the heart rate without affecting bronchial muscle tone, making it a safer option for patients with asthma. Therefore, diltiazem is the drug of choice for immediate management in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Propranolol:</strong> Propranolol is a beta-blocker, which can exacerbate bronchial asthma by causing bronchoconstriction. Thus, it is not a suitable choice for patients with asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Esmolol:</strong> Similar to propranolol, esmolol is a beta-blocker and can worsen asthma symptoms due to its bronchoconstrictive effects, making it unsuitable for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Propylthiouracil:</strong> This medication is used in the management of thyroid storm, a condition associated with severe hyperthyroidism. It is not relevant for rate control in atrial fibrillation and does not address the immediate needs of this patient's condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For immediate rate control in atrial fibrillation in a patient with bronchial asthma, non-dihydropyridine calcium channel blockers like diltiazem are preferred over beta-blockers to avoid exacerbating asthma symptoms.</span></p>",
      "correct_choice_id": 80993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55398,
      "choices": [
        {
          "id": 221053,
          "text": "<p><span style=\"font-size:12pt;\">Low volume blood patch</span></p>"
        },
        {
          "id": 221054,
          "text": "<p><span style=\"font-size:12pt;\">Increase caffeine</span></p>"
        },
        {
          "id": 221055,
          "text": "<p><span style=\"font-size:12pt;\">Fluid restriction</span></p>"
        },
        {
          "id": 221056,
          "text": "<p><span style=\"font-size:12pt;\">Stool softeners</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 24-year-old female who had a lumbar puncture continues to have a headache. Which of the following is not recommended? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7683813",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289632,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Fluid restriction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient is experiencing a post-dural puncture headache (PDPH), which can occur after a lumbar puncture due to the leakage of cerebrospinal fluid (CSF). This type of headache is typically treated with a variety of supportive measures to alleviate symptoms and promote healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fluid restriction is not recommended for patients with PDPH. &nbsp;In fact, liberal fluid intake is advised to help replace the lost CSF and maintain adequate hydration, which can aid in reducing the headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Low volume blood patch:</strong> An epidural blood patch is an effective treatment for PDPH, particularly in refractory cases. It involves injecting a small amount of the patient's own blood into the epidural space to seal the CSF leak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Increase caffeine:</strong> Caffeine is known to help reduce the severity of PDPH due to its vasoconstrictive properties, which can help alleviate the headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Stool softeners:</strong> Stool softeners are recommended to prevent straining during bowel movements, which can exacerbate the headache. Constipation is common in postoperative patients due to the use of anesthetics and other medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the management of post-dural puncture headache, fluid restriction is not recommended. Instead, measures such as epidural blood patches, increased caffeine intake, and stool softeners are utilized to manage symptoms and promote recovery.</span></p>",
      "correct_choice_id": 221055,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11569,
      "choices": [
        {
          "id": 46242,
          "text": "<p><span style=\"font-size:12.0pt;\">Area postrema syndrome</span></p>"
        },
        {
          "id": 46243,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myelitis</span></p>"
        },
        {
          "id": 46244,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal epilepsy</span></p>"
        },
        {
          "id": 46245,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic neuritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a major diagnostic criterion of neuromyelitis Optica? (INICET MAY 2021)</span></p>",
      "unique_key": "Q2781351",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289633,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) Focal epilepsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Neuromyelitis optica (NMO) spectrum disorder, also known as Devic's disease, is an autoimmune condition characterized by severe, recurrent episodes of optic neuritis and myelitis. The diagnostic criteria for NMO spectrum disorders include specific clinical syndromes. &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Focal epilepsy</strong> is not a diagnostic criterion for NMO. While seizures can occur in NMOSD due to brain lesions, focal epilepsy itself is not a major diagnostic feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Area postrema syndrome&nbsp;</strong>&nbsp;is major criteria. This is characterized by intractable nausea, vomiting, or hiccups, which is due to lesions in the area postrema of the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Acute myelitis</strong> is major criteria. Inflammation of the spinal cord, usually longitudinally extensive (spanning three or more vertebral segments).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Optic neuritis</strong> is major criteria. This involves inflammation of the optic nerve, leading to vision loss or impairment, often affecting both eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder (NMOSD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Most Common Core Clinical criteria:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Longitudinal extensive transverse myelitis (acute myelitis)</span></li><li><span style=\"font-size:12.0pt;\">Optic neuritis, often bilateral</span></li><li><span style=\"font-size:12.0pt;\">Area postrema syndrome</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Less Common Clinical Criteria:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Acute brainstem syndrome</span></li><li><span style=\"font-size:12.0pt;\">Acute diencephalic syndrome, which can manifest as symptomatic narcolepsy</span></li><li><span style=\"font-size:12.0pt;\">Symptomatic cerebral syndrome (symptomatic cerebral lesions)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some patients with NMOSD may have anti-NMO IgG antibody positivity, also known as anti-aquaporin 4 antibody (AQP4-IgG).</span></p>",
      "correct_choice_id": 46244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20265,
      "choices": [
        {
          "id": 81021,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 81022,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
        },
        {
          "id": 81023,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 81024,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old HIV patient presented with a painful lesion, as shown in the image. What is the most likely diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170516.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q6522920",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289634,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Kaposi sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma (KS) is a common malignancy in patients with HIV/AIDS. It is caused by human herpesvirus 8 (HHV-8) and typically presents as painless or painful, violaceous (purple) lesions on the skin and mucous membranes, including the oral cavity. The image shows such a lesion on the palate, which is characteristic of Kaposi sarcoma. These lesions are vascular in nature and can vary in color from red to purple, often with a raised or nodular appearance. In HIV patients, Kaposi sarcoma is an AIDS-defining condition and is often seen in those with significant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Basal cell carcinoma:</strong> This type of skin cancer usually occurs in sun-exposed areas of the skin and rarely affects mucous membranes. It typically presents as a pearly or waxy bump, not as multiple purple lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Malignant melanoma:</strong> While melanomas can appear as pigmented lesions, they are usually black or brown and rarely present as multiple violaceous lesions in the oral cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Squamous cell carcinoma:</strong> This type of cancer can occur in the oral cavity but usually presents as a non-healing ulcer or a raised, firm, scaly plaque. It does not have the characteristic color and appearance of Kaposi sarcoma lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma should be suspected in HIV patients presenting with violaceous lesions on the skin or mucous membranes. It is an AIDS-defining condition associated with HHV-8 infection.</span></p>",
      "correct_choice_id": 81022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11206,
      "choices": [
        {
          "id": 44790,
          "text": "<p><span style=\"font-size:12.0pt;\">PaO2/FiO2 ratio 200-300 mm/Hg</span></p>"
        },
        {
          "id": 44791,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral interstitial infiltrates</span></p>"
        },
        {
          "id": 44792,
          "text": "<p><span style=\"font-size:12.0pt;\">Symptom onset within a week</span></p>"
        },
        {
          "id": 44793,
          "text": "<p><span style=\"font-size:12.0pt;\">No cardiac failure on echocardiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the berlin definition, moderate ARDS is characterized by all, except: (NEET PG 2018)</span></p>",
      "unique_key": "Q4992857",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289635,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. PaO2/FiO2 ratio 200-300 mm/Hg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Berlin definition of Acute Respiratory Distress Syndrome (ARDS) classifies the severity based on the PaO2/FiO2 ratio assessed under specific conditions of oxygenation support. According to this definition, a PaO2/FiO2 ratio of 200-300 mmHg characterizes mild ARDS, not moderate ARDS. Moderate ARDS is defined by a PaO2/FiO2 ratio of 100-200 mm/Hg when assessed with at least 5 cm of water Positive End-Expiratory Pressure (PEEP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bilateral interstitial infiltrates:</strong> This is correct and consistent with all classifications of ARDS, which require bilateral opacities on imaging, either from chest radiographs or CT, indicative of pulmonary edema not fully explained by cardiac failure or fluid overload.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Symptom onset within a week:</strong> True for the Berlin definition, which stipulates that ARDS must occur within 7 days of a known clinical insult or new or worsening respiratory symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. No cardiac failure on echocardiography:</strong> Also true according to the Berlin definition, as the pulmonary edema should not be fully explained by cardiac failure or fluid overload, thus necessitating the exclusion of cardiac failure through echocardiography.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2012 Berlin Definition:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Onset within 7 days&nbsp;</strong>after a known clinical insult or new or worsening respiratory symptoms</span></li><li><span style=\"font-size:12.0pt;\">B/L opacities (Alveolar/Interstitial that are <strong>\"consistent with pulmonary edema\"</strong> on chest radiographs or chest CT)</span></li><li><span style=\"font-size:12.0pt;\">Minimum PEEP setting or CPAP, 5 cm of water.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PaO<sub>2</sub>: FiO<sub>2</sub> assessed on invasive mechanical ventilation (CPAP criterion used for the diagnosis of mild ARDS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Categorization of ARDS severity (on the basis of FiO<sub>2</sub>):</strong></i></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Mild: 200-300</span></li><li><span style=\"font-size:12.0pt;\">Moderate: 100-200</span></li><li><span style=\"font-size:12.0pt;\">Severe: &lt;100</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In resource limited settings <i><strong>Kigali Modifications&nbsp;</strong></i>was proposed (2016):</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Bilateral opacities could be documented by <i>either ultrasonography or chest radiograph</i>.</span></li><li><span style=\"font-size:12.0pt;\">Oxygenation criteria: pulse oximetry oxygen saturation <i><strong>(SpO<sub>2</sub>)/FiO<sub>2</sub> ratio ≤ 315 without the requirement for PEEP.</strong></i></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Respiratory Failure/Chap 301</strong></span></p>",
      "correct_choice_id": 44790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47637,
      "choices": [
        {
          "id": 190159,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 190160,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiloride</span></p>"
        },
        {
          "id": 190161,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 190162,
          "text": "<p><span style=\"font-size:12.0pt;\">Indapamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient having hypertension, is on thiazides and is complaining of fatigue and hypokalemia. Which of the following drug can prevent potassium loss?</span></p>",
      "unique_key": "Q5306021",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289636,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Amiloride</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazide diuretics, such as hydrochlorothiazide, indapamide, chlorthalidone, and metolazone, are known for causing potassium wasting, which can result in hypokalemia and associated symptoms like fatigue. To counteract this effect, potassium-sparing diuretics can be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiloride is an epithelial sodium channel (ENaC) inhibitor, which is a type of potassium-sparing diuretic. It helps prevent potassium loss by inhibiting sodium reabsorption in the distal tubules of the kidneys, thereby reducing potassium excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Furosemide</strong>: This is a loop diuretic, which also causes potassium wasting and is not suitable for preventing potassium loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acetazolamide</strong>: This is a carbonic anhydrase inhibitor diuretic, which is not typically used for potassium conservation and can also cause electrolyte imbalances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Indapamide</strong>: This is another thiazide-like diuretic, which also causes potassium wasting and does not prevent potassium loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiloride is a potassium-sparing diuretic that can be used to prevent potassium loss in patients on thiazide diuretics.</span></p>",
      "correct_choice_id": 190160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55349,
      "choices": [
        {
          "id": 220857,
          "text": "<p><span style=\"font-size:12pt;\">Pulsus bisferians</span></p>"
        },
        {
          "id": 220858,
          "text": "<p><span style=\"font-size:12pt;\">SBP fall from 80 mm Hg to 60 mm Hg during inspiration</span></p>"
        },
        {
          "id": 220859,
          "text": "<p><span style=\"font-size:12pt;\">Kussmaul breathing</span></p>"
        },
        {
          "id": 220860,
          "text": "<p><span style=\"font-size:12pt;\">Fine crepitations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 50-year-old man presents with pedal edema, abdominal distension, and distended neck veins. Chest X-ray is shown below. Which of the following will be seen? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-101359.png\" alt=\"\" width=\"300\" height=\"293\"></span></p>",
      "unique_key": "Q7387458",
      "question_audio": null,
      "question_video": null,
      "map_id": 16289637,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) SBP fall from 80 mm Hg to 60 mm Hg during inspiration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with symptoms indicative of right heart failure, such as pedal edema, abdominal distension, and distended neck veins. The chest X-ray shows an enlarged cardiac silhouette with maintained contours, suggesting a \"money bag\" heart appearance characteristic of pericardial effusion. The patient likely has a history of tuberculosis and&nbsp;might have developed constrictive pericarditis, then pericardial effusion and which progressed to tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Additionally, the combination of jugular venous distension and hypotension points towards cardiac tamponade. Pulsus paradoxus, a significant fall in systolic blood pressure during inspiration, is a hallmark of cardiac tamponade. In this case, the systolic BP fall from 80 mm Hg to 60 mm Hg during inspiration indicates pulsus paradoxus, confirming tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Pulsus bisferians: </strong>This is typically seen in conditions like severe aortic regurgitation, a combination of aortic stenosis and aortic regurgitation, or hypertrophic obstructive cardiomyopathy (HOCM). These conditions do not match the clinical presentation and X-ray findings of the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Kussmaul breathing: </strong>This type of deep and labored breathing is associated with severe <strong>metabolic acidosis,</strong> such as <strong>diabetic ketoacidosis</strong>. It is not related to the clinical scenario of pericardial effusion and cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Fine crepitations: </strong>Fine crepitations are a sign of pulmonary congestion often seen in <strong>left ventricular failure</strong>. In the case of cardiac tamponade, there is no pulmonary congestion as the blood is not effectively moving into the pulmonary circulation, thus crepitations would not be present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cardiac tamponade is characterized by pulsus paradoxus, which is a significant drop in systolic blood pressure during inspiration, often exceeding 10 mm Hg</span></p>",
      "correct_choice_id": 220858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}